{"content":"<li class=\"n-box-item date-title\" data-end=\"1532404799\" data-start=\"1532318400\" data-txt=\"Monday, December 23, 2019\">Monday, July 23, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3372620\" data-ts=\"1532386683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STLD\" target=\"_blank\">STLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372620-steel-dynamicsplus-2-after-beating-on-q2-earnings-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel Dynamics +2% after beating on Q2 earnings, revenues</a></h4><ul>     <li>Steel Dynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>)&nbsp;<font color='green'>+2.1%</font> after-hours as it posts better than expected <a href=\"https://seekingalpha.com/news/3372610-steel-dynamics-beats-0_04-beats-revenue\" target=\"_blank\">Q2 earnings</a> and revenues, and the company says it believes steel consumption will remain strong.</li>     <li>STLD says Q2 average product selling price for its steel operations rose $110 from Q1 to $932/ton, while the average ferrous scrap cost per ton melted&nbsp; increased $27 to $348/ton; the company's Q2 steel production utilization rate was 99%, compared to 94% in Q1 and 91% in the year-ago quarter.</li>     <li>STLD says it plans to increase production during H2 to ~40K tons/month and expects to reach an annual run-rate of 800K-900K tons of cold roll, pickled and oiled, and galvanized flat roll steel by mid-year 2019.</li>     <li>\"Based on strong domestic steel demand fundamentals and customer optimism, we believe steel consumption will continue to be strong for the remainder of the year,\"&nbsp;STLD says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372620\" data-linked=\"Steel Dynamics +2% after beating on Q2 earnings, revenues\" data-tweet=\"$STLD - Steel Dynamics +2% after beating on Q2 earnings, revenues https://seekingalpha.com/news/3372620-steel-dynamicsplus-2-after-beating-on-q2-earnings-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3372620-steel-dynamicsplus-2-after-beating-on-q2-earnings-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372615\" data-ts=\"1532384378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLX\" target=\"_blank\">HLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372615-helix-energyplus-8-after-strong-q2-results-raises-full-year-revenue-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helix Energy +8% after strong Q2 results, raises full-year revenue view</a></h4><ul>     <li>Helix Energy (NYSE:<a href='https://seekingalpha.com/symbol/HLX' title='Helix Energy Solutions Group, Inc.'>HLX</a>)&nbsp;<font color='green'>+8.5%</font> after-hours as it reports a strong <a href=\"https://seekingalpha.com/news/3372604-helix-energy-solutions-beats-0_05-beats-revenue\" target=\"_blank\">Q2 earnings</a> beat amid a 36% Y/Y revenue increase to $204M and adjusted EBITDA of $52.3M vs. $27.6M in Q1 and $29.7M in the prior-year quarter.</li>     <li>HLX slightly raises its FY 2018 revenue guidance to $695M-$750M from its previous outlook of $685M-$730M and $718M&nbsp;analyst consensus estimate; the company also sees EBITDA of $135M-$165M and capital  additions of $135M.</li>     <li>HLX says Q2 well intervention revenues rose 25%&nbsp;Q/Q to $32.2M due to higher utilization and rates in the North Sea, while robotics revenues jumped 44% to $11.9M driven primarily by the seasonal pick-up in activity and increased trenching in the North Sea.</li>     <li>Vessel utilization increased to 70% in Q2 compared to 57% in the same quarter of 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372615\" data-linked=\"Helix Energy +8% after strong Q2 results, raises full-year revenue view\" data-tweet=\"$HLX - Helix Energy +8% after strong Q2 results, raises full-year revenue view https://seekingalpha.com/news/3372615-helix-energyplus-8-after-strong-q2-results-raises-full-year-revenue-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3372615-helix-energyplus-8-after-strong-q2-results-raises-full-year-revenue-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372610\" data-ts=\"1532383317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STLD\" target=\"_blank\">STLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372610-steel-dynamics-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel Dynamics beats by $0.04, beats on revenue</a></h4><ul><li>Steel Dynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>): Q2 EPS of $1.53 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $3.1B (+29.7% Y/Y) <font color='green'>beats by $190M</font>.</li><li>Shares <font color='green'>+3%</font> AH.</li><li><a href='https://seekingalpha.com/pr/17223292-steel-dynamics-reports-record-second-quarter-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3372610\" data-linked=\"Steel Dynamics beats by $0.04, beats on revenue\" data-tweet=\"$STLD - Steel Dynamics beats by $0.04, beats on revenue https://seekingalpha.com/news/3372610-steel-dynamics-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3372610-steel-dynamics-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372604\" data-ts=\"1532382469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLX\" target=\"_blank\">HLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372604-helix-energy-solutions-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helix Energy Solutions beats by $0.05, beats on revenue</a></h4><ul><li>Helix Energy Solutions (NYSE:<a href='https://seekingalpha.com/symbol/HLX' title='Helix Energy Solutions Group, Inc.'>HLX</a>): Q2 EPS of $0.12 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $204.63M (+36.1% Y/Y) <font color='green'>beats by $19.07M</font>.</li><li>Shares <font color='green'>+6.86%</font> AH.</li><li><a href='https://seekingalpha.com/filing/4106164'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3372604\" data-linked=\"Helix Energy Solutions beats by $0.05, beats on revenue\" data-tweet=\"$HLX - Helix Energy Solutions beats by $0.05, beats on revenue https://seekingalpha.com/news/3372604-helix-energy-solutions-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3372604-helix-energy-solutions-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372594\" data-ts=\"1532381776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOGL\" target=\"_blank\">GOOGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372594-after-hours-gainers-losers-07-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (07/23/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+3.6%</font>. <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>&nbsp;<font color='green'>+3.0%</font>.<a href='https://seekingalpha.com/symbol/WERN' title='Werner Enterprises, Inc.'>WERN</a> <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+1.6%</font>. <a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a> <font color='green'>+1.6%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a> <font color='red'>-8.1%</font>. <a href='https://seekingalpha.com/symbol/NITE' title='Nightstar Therapeutics plc'>NITE</a> <font color='red'>-3.7%</font>. <a href='https://seekingalpha.com/symbol/ZION' title='Zions Bancorporation'>ZION</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color='red'>-2.7%</font>. <a href='https://seekingalpha.com/symbol/PAH-OLD' title='Platform Specialty Products Corp'>PAH-OLD</a> <font color='red'>-2.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372594\" data-linked=\"After Hours Gainers / Losers (07/23/2018)\" data-tweet=\"$GOOGL $GOOGL $STLD - After Hours Gainers / Losers (07/23/2018) https://seekingalpha.com/news/3372594-after-hours-gainers-losers-07-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3372594-after-hours-gainers-losers-07-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372586\" data-ts=\"1532380857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSI\" target=\"_blank\">VSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372586-vitamin-shoppe-names-godiva-chocolatiers-leite-new-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vitamin Shoppe names Godiva Chocolatier&#39;s Leite as new CEO</a></h4><ul>     <li>Vitamin Shoppe (NYSE:<a href='https://seekingalpha.com/symbol/VSI' title='Vitamin Shoppe, Inc.'>VSI</a>) appoints Godiva Chocolatier president Sharon Leite as its <a href=\"https://seekingalpha.com/pr/17223223-vitamin-shoppe-announces-new-chief-executive-officer\" target=\"_blank\">new CEO</a>, effective Aug. 27.</li>     <li>Leite was the President of Godiva Chocolatier in North America since October 2017 after serving as President of Sally Beauty, U.S. and Canada and spending nearly a decade at Pier 1 Imports.</li>     <li>Former CEO Colin Watts stepped down in May from the struggling specialty retailer of nutritional products.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372586\" data-linked=\"Vitamin Shoppe names Godiva Chocolatier&#39;s Leite as new CEO\" data-tweet=\"$VSI - Vitamin Shoppe names Godiva Chocolatier&#39;s Leite as new CEO https://seekingalpha.com/news/3372586-vitamin-shoppe-names-godiva-chocolatiers-leite-new-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3372586-vitamin-shoppe-names-godiva-chocolatiers-leite-new-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372583\" data-ts=\"1532380236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFN\" target=\"_blank\">INFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372583-infinera-acquires-coriant-for-430m-shares-halted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinera acquires Coriant for $430M; shares halted</a></h4><ul><li>Infinera (NASDAQ:<a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a>) <a href=\"https://seekingalpha.com/pr/17223217-infinera-scales-next-wave-global-network-spending-announces-intent-acquire-coriant\" target=\"_blank\">will acquire</a> network solutions company Coriant for $430M in cash and stock.</li><li>Coriant is a global supplier of open, hyperscale network solutions.</li><li>Infinera will pay $150M in cash at closing and estimated additional amounts of $25M in the two quarters post-closing plus $55M over a period of years. The company will also issue 21M shares.</li><li>Q2 guidance: Revenue is expected slightly higher than the midpoint of the previous range of $203M to $213M (consensus: $208.5M).</li><li>INFN shares were halted at 4:10 PM awaiting the news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372583\" data-linked=\"Infinera acquires Coriant for $430M; shares halted\" data-tweet=\"$INFN - Infinera acquires Coriant for $430M; shares halted https://seekingalpha.com/news/3372583-infinera-acquires-coriant-for-430m-shares-halted?source=tweet\" data-url=\"https://seekingalpha.com/news/3372583-infinera-acquires-coriant-for-430m-shares-halted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372570\" data-ts=\"1532379471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OI\" target=\"_blank\">OI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372570-owens-illinois-beats-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Owens-Illinois beats by $0.03, misses on revenue</a></h4><ul><li>Owens-Illinois (NYSE:<a href='https://seekingalpha.com/symbol/OI' title='Owens-Illinois, Inc.'>OI</a>):  EPS of $0.77 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $1.77B (+1.1% Y/Y) <font color='red'>misses by $50M</font>.</li><li>Shares <font color='green'>+1.54%</font>.</li><li><a href=\"https://www.sec.gov/Archives/edgar/data/812074/000110465918046540/a18-17602_1ex99d1.htm\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3372570\" data-linked=\"Owens-Illinois beats by $0.03, misses on revenue\" data-tweet=\"$OI - Owens-Illinois beats by $0.03, misses on revenue https://seekingalpha.com/news/3372570-owens-illinois-beats-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3372570-owens-illinois-beats-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372565\" data-ts=\"1532379043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYE\" target=\"_blank\">EYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372565-national-vision-launches-12m-share-stock-offering-shares-off-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Vision launches 12M-share stock offering; shares off 1% after hours</a></h4><ul><li>National Vision Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/EYE' title='National Vision Holdings'>EYE</a>) <a href=\"https://seekingalpha.com/pr/17223225-national-vision-announces-secondary-offering-12-million-shares-common-stock\" target=\"_blank\">commences </a>a public offering of 12M shares of common stock by existing investors. The company will receive no proceeds from the sales.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372565\" data-linked=\"National Vision launches 12M-share stock offering; shares off 1% after hours\" data-tweet=\"$EYE - National Vision launches 12M-share stock offering; shares off 1% after hours https://seekingalpha.com/news/3372565-national-vision-launches-12m-share-stock-offering-shares-off-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3372565-national-vision-launches-12m-share-stock-offering-shares-off-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372563\" data-ts=\"1532378807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZION\" target=\"_blank\">ZION</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372563-zions-drops-after-q2-hurt-competition-in-commercial-real-estate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zions drops after Q2 hurt by more competition in commercial real estate</a></h4><ul><li>Zions Bancorporation (NASDAQ:<a href='https://seekingalpha.com/symbol/ZION' title='Zions Bancorporation'>ZION</a>)<font color='red'> falls 3.5%</font>&nbsp;in after-hours trading a competitive commercial real estate market slowed loan growth in Q2.</li><li>Q2 EPS fell to 89 cents, trailing consensus, from $1.09 in Q1, but up from $73 cents Y/Y.</li><li>Net interest margin 3.56%, the same as in Q1, and up from 3.52% a year ago.</li><li>\"Competitive pressures in the market for commercial real estate loans led to additional runoff in that portfolio as we&rsquo;ve exercised discipline with respect to pricing and terms, muting overall loan growth,\" says Chairman and CEO Harris H. Simmons.</li><li>Commercial real estate loans of $10.97B fell 1% from $10.82B in Q1 and declined 2% from $11.20B in Q2 2017.</li><li>Common equity tier 1 capital ratio 12.2%, unchanged from Q1 and vs. 12.3% Y/Y.</li><li>Return on average common equity $10.6% vs. 13.3% in Q1 and 8.6% Y/Y.</li><li>Zions says recent regulatory changes should allow the bank to increase the pace of its capital distributions in the coming quarters.</li><li>It's also optimistic that, pending shareholder approval, it will be able to merge Zions Bancorporation into its ZB N.A. subsidiary by the end of Q3, creating a more efficient regulatory structure.</li><li>Source:&nbsp;<a href=\"https://seekingalpha.com/pr/17223134-zions-bancorporation-reports-second-quarter-financial-results\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3372534-zions-misses-0_03\" target=\"_blank\">Zions misses by $0.03</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372563\" data-linked=\"Zions drops after Q2 hurt by more competition in commercial real estate\" data-tweet=\"$ZION - Zions drops after Q2 hurt by more competition in commercial real estate https://seekingalpha.com/news/3372563-zions-drops-after-q2-hurt-competition-in-commercial-real-estate?source=tweet\" data-url=\"https://seekingalpha.com/news/3372563-zions-drops-after-q2-hurt-competition-in-commercial-real-estate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372561\" data-ts=\"1532378732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372561-celgenes-revlimid-successful-in-late-stage-lymphoma-study-shares-up-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene&#39;s Revlimid successful in late-stage lymphoma study; shares up 2% after hours</a></h4><ul><li>Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;after hours in response to its <a href=\"https://seekingalpha.com/pr/17223195-celgene-announces-phase-iii-augment-study-revlimid-combination-rituximab-r-treatment-patients\" target=\"_blank\">announcement </a>of successful results from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01938001?titles=augment&amp;lead=celgene&amp;rank=1\" target=\"_blank\">AUGMENT</a>, evaluating REVLIMID (lenalidomide) plus Roche's Rituxan (rituximab) in patients with relapsed/refractory indolent lymphoma.</li><li>The study met the primary endpoint of a statistically significant improvement in progression-free survival &#40;PFS&#41; compared to rituximab + placebo.</li><li>A favorable trend in overall survival was also observed but the data have not yet matured.</li><li>The results will be submitted for presentation at a future medical conference. Global regulatory submissions are on tap for Q1 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372561\" data-linked=\"Celgene&#39;s Revlimid successful in late-stage lymphoma study; shares up 2% after hours\" data-tweet=\"$CELG - Celgene&#39;s Revlimid successful in late-stage lymphoma study; shares up 2% after hours https://seekingalpha.com/news/3372561-celgenes-revlimid-successful-in-late-stage-lymphoma-study-shares-up-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3372561-celgenes-revlimid-successful-in-late-stage-lymphoma-study-shares-up-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372559\" data-ts=\"1532378650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RWT\" target=\"_blank\">RWT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372559-redwood-trust-raising-capital-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Redwood Trust raising capital; shares down 3%</a></h4><ul><li>Redwood Trust (NYSE:<a href='https://seekingalpha.com/symbol/RWT' title='Redwood Trust Inc'>RWT</a>) is taking advantage of its nice run higher of late, announcing a 6.25M share secondary. The underwriter greenshoe is for another 937.5K shares.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17223172-redwood-trust-announces-proposed-public-offering-common-stock\" target=\"_blank\">Press Release</a></li><li>Stock's&nbsp;<font color='red'>lower by 3%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3372559\" data-linked=\"Redwood Trust raising capital; shares down 3%\" data-tweet=\"$RWT - Redwood Trust raising capital; shares down 3% https://seekingalpha.com/news/3372559-redwood-trust-raising-capital-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3372559-redwood-trust-raising-capital-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372553\" data-ts=\"1532378474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHR\" target=\"_blank\">WHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372553-weak-profit-guidance-drags-down-whirlpool\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak profit guidance drags down Whirlpool</a></h4><ul><li>Whirlpool (NYSE:<a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a>) reports revenue in North America during Q2 was the same as last year at $2.8B. EBIT was 11.9% of sales as the favorable impact of product price/mix was offset by unit volume declines, raw material inflation and higher freight costs</li><li>For the EMEA business, revenue was $1.1B vs. $1.2B&nbsp; a year ago and EBIT was -$25M vs. $2M a year ago as unit volume fell off.</li><li>For the Latin America business, revenue was $852M vs. $986M a year ago and EBIT was $33M vs $57M.</li><li>For the Asia business, revenue was $428M vs. $373M a year ago and EBIT was $43M vs. -$30M.</li><li>Looking ahead, Whirlpool expects to generate cash from operating activities of approximately $1.5B&nbsp;and free cash flow of approximately $850M. EPS of $14.20 to $14.80 is anticipated vs. $15.62 consensus.</li><li>Shares of Whirlpool are&nbsp;<font color='red'>down 8.8%</font>&nbsp;in AH trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372548-whirlpool-misses-0_49-misses-revenue\" target=\"_blank\">Whirlpool misses by $0.49, misses on revenue</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372553\" data-linked=\"Weak profit guidance drags down Whirlpool\" data-tweet=\"$WHR - Weak profit guidance drags down Whirlpool https://seekingalpha.com/news/3372553-weak-profit-guidance-drags-down-whirlpool?source=tweet\" data-url=\"https://seekingalpha.com/news/3372553-weak-profit-guidance-drags-down-whirlpool\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372535\" data-ts=\"1532377453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDR\" target=\"_blank\">ALDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372535-alder-bio-business-chief-to-bid-adieu-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alder Bio business chief to bid adieu; shares down 1% after hours</a></h4><ul><li>Alder Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/1423824/000119312518223685/d527798d8k.htm\" target=\"_blank\">reports </a>that Chief Business Officer, Treasurer and Secretary Mark Litton will leave the company on August 1 to pursue another opportunity. He has agreed to serve as a consultant for 12 months from the date of his departure.</li><li>Shares are off&nbsp;<font color='red'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372535\" data-linked=\"Alder Bio business chief to bid adieu; shares down 1% after hours\" data-tweet=\"$ALDR - Alder Bio business chief to bid adieu; shares down 1% after hours https://seekingalpha.com/news/3372535-alder-bio-business-chief-to-bid-adieu-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3372535-alder-bio-business-chief-to-bid-adieu-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372527\" data-ts=\"1532377010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMSI\" target=\"_blank\">MMSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372527-merit-medical-q2-top-line-up-21-earnings-up-15-guidance-raised-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merit Medical Q2 top line up 21%; earnings up 15%; guidance raised; shares up 1% after hours</a></h4><ul><li>Merit Medical Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MMSI' title='Merit Medical Systems, Inc.'>MMSI</a>) <a href=\"https://seekingalpha.com/pr/17223088-merit-medical-reports-record-revenues-second-quarter-2018-merit-adjusts-2018-guidance\" target=\"_blank\">Q2 results </a>($M): Total sales: 224.8 (+20.5%); Stand-alone devices: 92.5 (+30.1%).</li><li>Net income: 10.9 (+14.7%); non-GAAP net income: 27.0 (+8.0%); EPS: 0.21 (+10.5%); non-GAAP EPS: 0.43 (+19.4%).</li><li><strong>2018 guidance</strong>: Sales: $870M - 880M from $838M - 851M; EPS; $0.80 - 0.90 from $0.77 - 0.85; non-GAAP EPS: $1.60 - 1.70 from $1.57 - 1.69.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372527\" data-linked=\"Merit Medical Q2 top line up 21%; earnings up 15%; guidance raised; shares up 1% after hours\" data-tweet=\"$MMSI - Merit Medical Q2 top line up 21%; earnings up 15%; guidance raised; shares up 1% after hours https://seekingalpha.com/news/3372527-merit-medical-q2-top-line-up-21-earnings-up-15-guidance-raised-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3372527-merit-medical-q2-top-line-up-21-earnings-up-15-guidance-raised-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372519\" data-ts=\"1532376830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372519-alphabet-nears-5-evening-gains-on-paid-clicks-revenues-jump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alphabet nears 5% evening gains on paid clicks, revenues jump</a></h4><ul>   <li>Alphabet shares are jumping (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+4.6%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+4.7%</font>) after an easy beat on top and bottom lines in its <a href=\"https://seekingalpha.com/news/3372508-alphabet-beats-2_21-beats-revenue\" target=\"_blank\">Q2 earnings</a> with a heavy jump in paid clicks.</li>    <li>Revenues were up 26% (up 23% in constant currency). Operating income fell to $2.81B and operating margin dropped to 9% from 16%, inclusive of the EU fines of &euro;4.34B.</li>    <li>Excluding the fines, net income rose to $8.266B from $6.26B; inclusive of the fines, it dipped to $3.195B from $3.524B.</li>    <li>Revenue ex-TAC was $26.24B, beating an expected $25.6B.</li>    <li>Revenue by segment: Google properties, $23.3B (up 26.3%); Google Network Members' properties revenues, $4.825B (up 13.6%); Google other revenues, $4.425B (up 36.5%); Other bets, $145M (up 49.5%).</li>    <li>Paid clicks rose 58% Y/Y and were up 15% from the first quarter. Cost-per-click on Google properties fell 22% Y/Y (and fell 10% Q/Q).</li>    <li><a href=\"http://abc.xyz/investor\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://abc.xyz/investor/pdf/2018Q2_alphabet_earnings_release.pdf\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3372519\" data-linked=\"Alphabet nears 5% evening gains on paid clicks, revenues jump\" data-tweet=\"$GOOG $GOOG $GOOGL - Alphabet nears 5% evening gains on paid clicks, revenues jump https://seekingalpha.com/news/3372519-alphabet-nears-5-evening-gains-on-paid-clicks-revenues-jump?source=tweet\" data-url=\"https://seekingalpha.com/news/3372519-alphabet-nears-5-evening-gains-on-paid-clicks-revenues-jump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372509\" data-ts=\"1532376335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLUE\" target=\"_blank\">BLUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372509-bluebird-bio-readies-400m-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bluebird bio readies $400M stock offering</a></h4><ul><li>Bluebird bio (NASDAQ:<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>) <a href=\"https://seekingalpha.com/pr/17223078-bluebird-bio-announces-proposed-public-offering-common-stock\" target=\"_blank\">launches</a> a $400M public offering of common stock. Price, volume and terms have yet to be announced. Shares are off a fraction after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372509\" data-linked=\"Bluebird bio readies $400M stock offering\" data-tweet=\"$BLUE - Bluebird bio readies $400M stock offering https://seekingalpha.com/news/3372509-bluebird-bio-readies-400m-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3372509-bluebird-bio-readies-400m-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372508\" data-ts=\"1532376321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372508-alphabet-beats-2_21-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alphabet beats by $2.21, beats on revenue</a></h4><ul><li>Alphabet (NASDAQ:<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>): Q2 Adj. EPS of $11.75 <font color='green'>beats by $2.21</font>.</li><li>Revenue of $32.66B (+25.6% Y/Y) <font color='green'>beats by $530M</font>.</li><li>Fine impact of $7.21 on EPS.</li><li>Shares <font color='green'>+2.7%</font>.</li><li><a href=\"https://abc.xyz/investor/pdf/2018Q2_alphabet_earnings_release.pdf\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3372508\" data-linked=\"Alphabet beats by $2.21, beats on revenue\" data-tweet=\"$GOOG $GOOGL - Alphabet beats by $2.21, beats on revenue https://seekingalpha.com/news/3372508-alphabet-beats-2_21-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3372508-alphabet-beats-2_21-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372498\" data-ts=\"1532374365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372498-windstream-default-trial-begins-focus-on-subsidiaries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream default trial begins with focus on subsidiaries</a></h4><ul>   <li>The trial is under way over Aurelius' allegations of default at Windstream Holdings (<a href=\"http://seekingalpha.com/symbol/WIN\" target=\"_blank\">WIN</a> <font color='red'>-2%</font>) in its 2015 transaction with Uniti Group (<a href=\"http://seekingalpha.com/symbol/UNIT\" target=\"_blank\">UNIT</a> <font color='red'>-0.8%</font>), with lawyers for U.S. Bank and Windstream questioning the company's John Fletcher.</li>    <li>Both sides are starting out by delving into details of which Windstream entities were part of the transaction and what Windstream told regulators at the time, Bloomberg reports.</li>    <li>Fletcher acknowledges some wording was \"imprecise\" in the documents: \"This was one of the most complex deals I've ever worked on.\" But the benefits of the deal were clear at the time, he says, including for customers.</li>    <li>U.S. Bank's lawyer has presented Windstream's statements to regulators that Windstream subsidiaries transferred assets to then-named Communications Sales &amp; Leasing with a plan to lease them back; Windstream's lawyer counters that it was Windstream Holdings and not the subsidiaries leasing back the assets.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3371032-windstream-minus-12-percent-uniti-minus-5_6-percent-citi-pulls-sell-switch\" target=\"_blank\">Windstream -12%, Uniti -5.6% as Citi pulls Sell switch</a> (Jul. 18 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3370119-windstream-amends-exchange-offers-new-dates-rates\" target=\"_blank\">Windstream amends exchange offers with new dates, rates</a> (Jul. 14 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372498\" data-linked=\"Windstream default trial begins with focus on subsidiaries\" data-tweet=\"$WIN $WINMQ $UNIT - Windstream default trial begins with focus on subsidiaries https://seekingalpha.com/news/3372498-windstream-default-trial-begins-focus-on-subsidiaries?source=tweet\" data-url=\"https://seekingalpha.com/news/3372498-windstream-default-trial-begins-focus-on-subsidiaries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372496\" data-ts=\"1532373646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UHS\" target=\"_blank\">UHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372496-hospital-operators-in-green-on-lifepoint-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hospital operators in the green on LifePoint deal</a></h4><ul><li>Community Health Systems is not the only hospital operator benefitting from investors' enthusiasm for the industry after the LifePoint Health merger announced earlier today.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services Inc.'>UHS</a> <font color='green'>+2.5%</font>)(<a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/SSY' title='SunLink Health Systems, Inc'>SSY</a> <font color='green'>+0.6%</font>)(<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color='green'>+2.6%</font>)(<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='green'>+4.1%</font>)(<a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a>)(<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+7.6%</font>)(<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a> <font color='green'>+0.3%</font>)(<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color='green'>+0.1%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372261-lifepoint-health-merge-rcch-healthcare-partners-65-share-shares-34-percent-premarket\" target=\"_blank\">LifePoint Health to merge with RCCH HealthCare Partners at $65/share; shares up 34% premarket.</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372496\" data-linked=\"Hospital operators in the green on LifePoint deal\" data-tweet=\"$UHS $UHS $SGRY - Hospital operators in the green on LifePoint deal https://seekingalpha.com/news/3372496-hospital-operators-in-green-on-lifepoint-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3372496-hospital-operators-in-green-on-lifepoint-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372493\" data-ts=\"1532373509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372493-tesla-clarifies-on-supplier-costs-issue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla clarifies on supplier costs issue</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) is <font color='red'>down 3.26%</font> to $303.37 after trading in a range of $292.86 to $305.50 today amid a lot of discussion over supplier issues.</li><li>Not everyone thinks the wheel are falling off. Baird analyst Ben Kallo maintains that Tesla is asking for supplier concessions from a position of strength and observes that the development could indicate that Model 3 production is ramping. Kallo recommends buying Tesla on the weakness in share price.</li> <li>In a <a href=\"https://twitter.com/timkhiggins/status/1021456126011834368\" target=\"_blank\">statement</a> provided by Tesla, the company clarifies that it asked fewer than 10 suppliers for a reduction in total capex project spend for long-term projects that began in 2016 but aren't completed yet - and continues to discuss future parts costs with suppliers as a standard part of the procurement process.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372301-tesla-minus-4-percent-pressing-suppliers-cash\" target=\"_blank\">Tesla -4% after pressing suppliers for cash</a> (July 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372442-investors-send-tesla-300-back\" target=\"_blank\">Investors send Tesla below $300 and back</a> (July 23)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3372493\" data-linked=\"Tesla clarifies on supplier costs issue\" data-tweet=\"$TSLA - Tesla clarifies on supplier costs issue https://seekingalpha.com/news/3372493-tesla-clarifies-on-supplier-costs-issue?source=tweet\" data-url=\"https://seekingalpha.com/news/3372493-tesla-clarifies-on-supplier-costs-issue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>217&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372492\" data-ts=\"1532373213\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDCO\" target=\"_blank\">PDCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372492-dental-stocks-perk-up-on-possible-sentiment-shift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dental stocks perk up on possible sentiment shift</a></h4><ul><li>Dental products players Patterson Companies (<a href='https://seekingalpha.com/symbol/PDCO' title='Patterson Companies Inc.'>PDCO</a> <font color='green'>+2.9%</font>), Henry Schein (<a href='https://seekingalpha.com/symbol/HSIC' title='Henry Schein, Inc.'>HSIC</a> <font color='green'>+1.7%</font>) and DENTSPLY SIRONA (<a href='https://seekingalpha.com/symbol/XRAY' title='DENTSPLY SIRONA, Inc'>XRAY</a> <font color='green'>+3.4%</font>) are all in the green and all trying to climb out of long-term downtrends.</li><li>Baird's Jeff Johnson says sentiment (and valuations) had gotten so low that bargain hunters are finally moving in.</li><li>Last week, Danaher announced plans to spin off its dental business.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3371448-danaher-spin-dental-business-shares-7-percent-premarket\" target=\"_blank\">Danaher to spin off dental business; shares up 7% premarket</a> (July 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372492\" data-linked=\"Dental stocks perk up on possible sentiment shift\" data-tweet=\"$PDCO $PDCO $HSIC - Dental stocks perk up on possible sentiment shift https://seekingalpha.com/news/3372492-dental-stocks-perk-up-on-possible-sentiment-shift?source=tweet\" data-url=\"https://seekingalpha.com/news/3372492-dental-stocks-perk-up-on-possible-sentiment-shift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372486\" data-ts=\"1532372137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRH\" target=\"_blank\">AMRH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372486-technology-top-5-gainers-losers-of-2_55-pm-07-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (07/23/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/AMRH' title='Ameri Holdings, Inc.'>AMRH</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SPCB' title='SuperCom, Ltd.'>SPCB</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='green'>+9%</font>.</li>      <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/NTGR' title='NETGEAR, Inc.'>NTGR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SCWX' title='SecureWorks Corp.'>SCWX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372486\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (07/23/2018)\" data-tweet=\"$AMRH $AMRH $NIHD - Technology - Top 5 Gainers / Losers as of 2.55 PM (07/23/2018) https://seekingalpha.com/news/3372486-technology-top-5-gainers-losers-of-2_55-pm-07-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3372486-technology-top-5-gainers-losers-of-2_55-pm-07-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372479\" data-ts=\"1532371137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUR\" target=\"_blank\">CUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372479-neuralstem-up-21-on-nsiminus-189-data-in-alzheimers-model\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neuralstem up 21% on NSI-189 data in Alzheimer&#39;s model</a></h4><ul><li>Thinly traded nano cap Neuralstem (<a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='green'>+21.4%</font>) is up on almost a 10x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/17222900-neuralstem-announces-presentation-preclinical-data-demonstrating-neurogenic-compound-nsiminus\" target=\"_blank\">announcement </a>of encouraging preclinical data on NSI-189 in a mouse model of Alzheimer's disease &#40;AD&#41;. The results were presented at the Alzheimer's Association International Conference in Chicago.</li><li>Mice treated with NSI-189 (orally) experienced improved learning ability and retention as measured by a simple task and improved performance on a short-term memory test. Treated AD mice also scored well on a motor learning test called Rotarod while experiencing decreased anxiety levels.</li><li>The company says small molecule&nbsp;<a href=\"https://www.neuralstem.com/pipeline/ns-189\" target=\"_blank\">NSI-189</a>, a benzylpiperazine-aminopyridine, stimulates neurogenesis, synaptogenesis and increases hippocampal volume, all of which play a role in reversing depression, enhancing cognition and promoting the growth of new nerve tissue. It is in clinical development for major depressive disorder.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316367-neuralstems-lead-candidate-nsiminus-189-shows-potential-efficacy-mdd-40-mg-dose-shares-ahead\" target=\"_blank\">Neuralstem's lead candidate NSI-189 shows potential efficacy in MDD at 40 mg dose; shares ahead 67%</a> (Dec. 5, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372479\" data-linked=\"Neuralstem up 21% on NSI-189 data in Alzheimer&#39;s model\" data-tweet=\"$CUR $SNCA - Neuralstem up 21% on NSI-189 data in Alzheimer&#39;s model https://seekingalpha.com/news/3372479-neuralstem-up-21-on-nsiminus-189-data-in-alzheimers-model?source=tweet\" data-url=\"https://seekingalpha.com/news/3372479-neuralstem-up-21-on-nsiminus-189-data-in-alzheimers-model\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372472\" data-ts=\"1532368843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCLP\" target=\"_blank\">HCLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372472-energy-materials-top-5-gainers-losers-of-2-00-pm-07-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/23/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HCLP' title='Hi-Crush Partners LP'>HCLP</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/BRN' title='Barnwell Industries, Inc'>BRN</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SXT' title='Sensient Technologies Corporation'>SXT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372472\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/23/2018)\" data-tweet=\"$HCLP $HCR $BRN - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/23/2018) https://seekingalpha.com/news/3372472-energy-materials-top-5-gainers-losers-of-2-00-pm-07-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3372472-energy-materials-top-5-gainers-losers-of-2-00-pm-07-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372469\" data-ts=\"1532368211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXPI\" target=\"_blank\">NXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372469-nxp-qcom-recover-on-chinese-media-report-of-positive-turn\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NXP, QCOM recover on Chinese media report of &quot;positive turn&quot;</a></h4><ul><li>        NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>) recovers some of its early morning losses on a South China Morning Post <a href=\"https://www.scmp.com/business/companies/article/2156529/deadline-looms-us-china-trade-war-leaves-fate-qualcomm-nxp-merger\" target=\"_blank\">article</a> suggesting that its Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) deal could take a &ldquo;positive turn.&rdquo;</li><li>                  Post sources say that the Ministry of Industry and Information Technology of China has &ldquo;become more favorable toward the purchase.&rdquo;    </li><li>               NXP shares are&nbsp;<font color='red'>down 2%</font>&nbsp;to $101.28 after an intraday low of $99.80.&nbsp;</li><li>               Qualcomm shares are<font color='green'>&nbsp;</font><font color='green'>up 0.7%</font>&nbsp;to $59.01.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372407-nxp-minus-2-percent-ahead-wednesdays-qualcomm-deal-deadline\" target=\"_blank\">NXP -2% ahead of Wednesday's Qualcomm deal deadline</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372469\" data-linked=\"NXP, QCOM recover on Chinese media report of &quot;positive turn&quot;\" data-tweet=\"$NXPI $NXPI $QCOM - NXP, QCOM recover on Chinese media report of &quot;positive turn&quot; https://seekingalpha.com/news/3372469-nxp-qcom-recover-on-chinese-media-report-of-positive-turn?source=tweet\" data-url=\"https://seekingalpha.com/news/3372469-nxp-qcom-recover-on-chinese-media-report-of-positive-turn\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>108&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372468\" data-ts=\"1532368158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYPL\" target=\"_blank\">PYPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372468-third-point-sees-paypal-upside-potential-50-within-18-months\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Third Point sees PayPal upside potential ~50% within 18 months</a></h4><ul><li><a href=\"https://www.valuewalk.com/2018/07/dan-loeb-q2-2018-full-letter-pdf-paypal/\" target=\"_blank\">Third Point forecasts</a> \"above-consensus EPS growth driving shares to $125 within 18 months, for ~50%&nbsp; upside\" for PayPal (<a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a> <font color='green'>+1.9%</font>) as it expands organically and through acquisitions, Dan Loeb writes in his Q2 investors letter.</li><li>Third Point initiated a long position in PayPal in Q2, the letter discloses.</li><li>Venmo, its peer-to-peer platform, can contribute $1B in annual revenue within three years, Loeb writes. Other reasons for optimism include PayPal's shift to dynamic pricing away from \"one-size-fits-all\" pricing approach and its expansion to offline merchants through its iZettle acquisition.</li><li>Third Point also sees an opportunity for PayPal to improve its operating margins, which at 25% is 20-40 points lower than large-cap payment peers such as Visa, Mastercard, and WorldPay.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372421-third-point-takes-stake-paypal\" target=\"_blank\">Third Point takes stake in PayPal</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372468\" data-linked=\"Third Point sees PayPal upside potential ~50% within 18 months\" data-tweet=\"$PYPL - Third Point sees PayPal upside potential ~50% within 18 months https://seekingalpha.com/news/3372468-third-point-sees-paypal-upside-potential-50-within-18-months?source=tweet\" data-url=\"https://seekingalpha.com/news/3372468-third-point-sees-paypal-upside-potential-50-within-18-months\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372467\" data-ts=\"1532368126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDE\" target=\"_blank\">DDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372467-dover-downs-bid-up-51-on-merger-euphoria\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dover Downs bid up 51% on merger euphoria</a></h4><ul> <li>Dover Downs Gaming &amp; Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/DDE' title='Dover Downs Gaming & Entertainment, Inc.'>DDE</a>) is <font color='green'>up 50.99%</font> after the company discloses its plans to merger with Twin River Worldwide.</li> <li>\"We believe this transaction will help us grow our business, invest in our people and our facilities and compete more effectively given changes in gaming on the horizon,\" says Dover Downs CEO Denis McGlynn.</li> <li>The Dover board has already approved the deal, setting it up for a shareholder vote.</li> <li>Twin River already operates assets in the South (Biloxi, Mississippi), West (Aurora, Colorado) and Northeast (Lincoln and Tiverton, Rhode Island (opening shortly)) regions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372467\" data-linked=\"Dover Downs bid up 51% on merger euphoria\" data-tweet=\"$DDE - Dover Downs bid up 51% on merger euphoria https://seekingalpha.com/news/3372467-dover-downs-bid-up-51-on-merger-euphoria?source=tweet\" data-url=\"https://seekingalpha.com/news/3372467-dover-downs-bid-up-51-on-merger-euphoria\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372463\" data-ts=\"1532367374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUYA\" target=\"_blank\">HUYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372463-huya-yy-competitor-considers-us-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huya, YY competitor considers US IPO</a></h4><ul><li>        Chinese online gaming portal Douyu is <a href=\"https://www.chinamoneynetwork.com/2018/07/23/tencent-backed-game-streaming-platform-douyu-said-to-raise-700m-in-us-ipo\" target=\"_blank\">considering a $700M IPO</a> in the US, according to local media reports.</li><li>               Douyu was considering a Hong Kong listing like competitor Inke, but will now debut in the US like peer Huya (<a href='https://seekingalpha.com/symbol/HUYA' title='Huya Broadcasting'>HUYA</a> <font color='red'>-3.6%</font>).&nbsp;</li><li>               Douyu streams videos including sports events, online games, and entertainment. The company tops the market along with Huya and YY (<a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> <font color='red'>-3.2%</font>) with market penetration of 4.25%, 3.61%, and 3.33%, respectively. &nbsp;&nbsp;</li><li>               Douya has a $1.5B valuation, according to China Money Network.&nbsp;</li><li>               In March, Tencent (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holding Ltd. ADR'>OTCPK:TCEHY</a>, <a href='https://seekingalpha.com/symbol/TCTZF' title='Tencent Holding Ltd.'>OTCPK:TCTZF</a>) invested $632M in Douyu and led a $462M round in Huya.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3355891-huya-opens-trading-ipo-shares-33-percent\" target=\"_blank\">Huya opens trading from IPO; shares up 33%</a> (May 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372463\" data-linked=\"Huya, YY competitor considers US IPO\" data-tweet=\"$HUYA $HUYA $YY - Huya, YY competitor considers US IPO https://seekingalpha.com/news/3372463-huya-yy-competitor-considers-us-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3372463-huya-yy-competitor-considers-us-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372457\" data-ts=\"1532366178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372457-activist-investor-pops-out-barnes-noble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activist investor pops out at Barnes &amp; Noble</a></h4><ul> <li>Barnes &amp; Noble (<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a> <font color='green'>+0.5%</font>) jumps after Schottenfeld discloses a 5.7% active stake in the retailer.</li> <li>Schottenfeld says it's pushing the B&amp;N board and shareholders on exploring strategic options.</li> <li>Shares of Barnes &amp; Noble were in negative territory earlier in the day.</li> <li><a href=\"https://seekingalpha.com/filing/4105564\" target=\"_blank\">SEC Form 13D</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3372457\" data-linked=\"Activist investor pops out at Barnes &amp; Noble\" data-tweet=\"$BKS - Activist investor pops out at Barnes &amp; Noble https://seekingalpha.com/news/3372457-activist-investor-pops-out-barnes-noble?source=tweet\" data-url=\"https://seekingalpha.com/news/3372457-activist-investor-pops-out-barnes-noble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372456\" data-ts=\"1532366101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JPM\" target=\"_blank\">JPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372456-financial-stocks-gain-2-yearminus-10-year-treasury-yield-spread-widens\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financial stocks gain as 2 year-10 year Treasury yield spread widens</a></h4><ul><li>Financials gain as the spread between the 2-year and 10-year Treasury yields widens to 34 basis points from 24 bps five days ago.</li><li>10-year Treasury fell, boosting yield about 6 basis points to almost 2.96%, while the 2-year's decline improved its yield by almost 3 basis points to 2.62%.</li><li>S&amp;P Financial Sector Index<font color='green'> gains 1.4%</font>&nbsp;in early afternoon trading to 463.81; the index has risen 4.2% in the past month, but about flat year-to-date.</li><li>Among the big banks, JPMorgan Chase (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='green'>+2.5%</font>) shows the most improvement, followed by Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='green'>+2.3%</font>) and Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='green'>+2.1%</font>).</li><li>Biggest movers among the regionals are SunTrust (<a href='https://seekingalpha.com/symbol/STI' title='SunTrust Banks, Inc.'>STI</a> <font color='green'>+2.4%</font>), Fifth Third Bancorp (<a href='https://seekingalpha.com/symbol/FITB' title='Fifth Third Bancorp'>FITB</a> <font color='green'>+2.2%</font>), and Regions Financial (<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a> <font color='green'>+2%</font>).</li><li>Brighthouse Financial (<a href='https://seekingalpha.com/symbol/BHF' title='Brighthouse Financial, Inc.'>BHF</a> <font color='green'>+3.9%</font>) leads life insurers; while Aflac (<a href='https://seekingalpha.com/symbol/AFL' title='Aflac Incorporated'>AFL</a> <font color='green'>+1.2%</font>) heads up property and casualty insurers.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372008-dollar-index-slips-trump-keeps-criticism-feds-interest-rate-hikes\" target=\"_blank\">Dollar index slips as Trump keeps up criticism on Fed's interest rate hikes</a> (July 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372456\" data-linked=\"Financial stocks gain as 2 year-10 year Treasury yield spread widens\" data-tweet=\"$JPM $JPM $WFC - Financial stocks gain as 2 year-10 year Treasury yield spread widens https://seekingalpha.com/news/3372456-financial-stocks-gain-2-yearminus-10-year-treasury-yield-spread-widens?source=tweet\" data-url=\"https://seekingalpha.com/news/3372456-financial-stocks-gain-2-yearminus-10-year-treasury-yield-spread-widens\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372453\" data-ts=\"1532365235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LX\" target=\"_blank\">LX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372453-financials-top-gainers-losers-of-1-00-pm-07-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (07/23/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LX' title='LexinFintech Holdings Ltd. ADS'>LX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/EXPI' title='eXp World Holdings, Inc.'>EXPI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/MBFI' title='MB Financial Inc.'>MBFI</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372453\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (07/23/2018)\" data-tweet=\"$LX $LX $FINV - Financials - Top Gainers / Losers as of 1:00 PM (07/23/2018) https://seekingalpha.com/news/3372453-financials-top-gainers-losers-of-1-00-pm-07-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3372453-financials-top-gainers-losers-of-1-00-pm-07-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372452\" data-ts=\"1532365231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDXG\" target=\"_blank\">MDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372452-mimedx-holds-steady-after-wsj-article\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MiMedx holds steady after WSJ article</a></h4><ul><li>Embattled MiMedx (<a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a> <font color='green'>+0.1%</font>) is treading water on below-average volume on the heels of a <a href=\"https://www.wsj.com/articles/highflying-medical-firm-a-help-to-wounded-veterans-falls-to-earth-1532362069\" target=\"_blank\">Wall Street Journal article</a> rehashing the company's alleged misbehavior in booking sales of its skin grafts.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367395-ceo-petit-mimedx\" target=\"_blank\">CEO Petit out at MiMedx</a> (July 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362290-mimedx-restate-six-years-financial-statements-withdraws-2018-guidance\" target=\"_blank\">MiMedx to restate six years of financial statements, withdraws 2018 guidance</a> (June 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372452\" data-linked=\"MiMedx holds steady after WSJ article\" data-tweet=\"$MDXG - MiMedx holds steady after WSJ article https://seekingalpha.com/news/3372452-mimedx-holds-steady-after-wsj-article?source=tweet\" data-url=\"https://seekingalpha.com/news/3372452-mimedx-holds-steady-after-wsj-article\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372449\" data-ts=\"1532364327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETS\" target=\"_blank\">PETS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372449-petmed-express-down-14-after-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PetMed Express down 14% after Q2 results</a></h4><ul><li>Investors are punishing PetMed Express (<a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='red'>-13.7%</font>) after its modest $0.01 Q2 earnings miss on higher-than-expected sales.</li><li>Investors are heading for exits in apparent response to higher costs. In the conference call this morning, CEO Menderes Akdag said new customer acquisition cost rose to $40 from $37 yoy, advertising expenses went up and the company cut prices on certain products due to increased online competition, with further cuts likely.</li><li>Gross margin eased a bit to 34,3%, down a modest 0.2% yoy, while operating earnings yield slipped 0.1% to 18.0%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372315-petmed-express-q1-top-line-10-percent-eps-38-percent\" target=\"_blank\">PetMed Express Q1 top line up 10%; EPS up 38%</a> (July 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372295-petmed-express-misses-0_01-beats-revenue\" target=\"_blank\">PetMed Express misses by $0.01, beats on revenue</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372449\" data-linked=\"PetMed Express down 14% after Q2 results\" data-tweet=\"$PETS - PetMed Express down 14% after Q2 results https://seekingalpha.com/news/3372449-petmed-express-down-14-after-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3372449-petmed-express-down-14-after-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372448\" data-ts=\"1532364208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLSNY\" target=\"_blank\">TLSNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372448-teliaplus-3_4-amid-insider-buying\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telia +3.4% amid insider buying</a></h4><ul>   <li>Telia ADRs (<a href='https://seekingalpha.com/symbol/TLSNY' title='Telia Company AB ADR'>OTCPK:TLSNY</a>) are <font color='green'>up 3.4%</font> on high volume after key insider buys.</li>    <li>CEO Johan Dennelind has bought 20,000 shares, Bloomberg reports, and Chairman Marie Ehrling has bought 10,000 shares.</li>    <li>Emil Nilsson (head of Lithuania, Estonia and Denmark) has bought 20,000 shares as well.</li>    <li>The Swedish company last week <a href=\"https://seekingalpha.com/news/3372093-telia-1b-deal-buy-bonnier-broadcasting\" target=\"_blank\">sealed a $1B deal</a> to expand its media business through an acquisition of family-owned Bonnier Broadcasting.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372448\" data-linked=\"Telia +3.4% amid insider buying\" data-tweet=\"$TLSNY $TLSNF - Telia +3.4% amid insider buying https://seekingalpha.com/news/3372448-teliaplus-3_4-amid-insider-buying?source=tweet\" data-url=\"https://seekingalpha.com/news/3372448-teliaplus-3_4-amid-insider-buying\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372447\" data-ts=\"1532364001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDE\" target=\"_blank\">DDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372447-midday-gainers-losers-07-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (07/23/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/DDE' title='Dover Downs Gaming & Entertainment, Inc.'>DDE</a> <font color='green'>+52%</font>. <a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color='green'>+43%</font>. <a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/OMNT' title='Ominto, Inc.'>OTCPK:OMNT</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/HCLP' title='Hi-Crush Partners LP'>HCLP</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/AMRH' title='Ameri Holdings, Inc.'>AMRH</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a> <font color='green'>+15%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/BBGI' title='Beasley Broadcast Group, Inc.'>BBGI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SSLJ' title='SSLJ. COM LTD'>SSLJ</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SEII' title='Sharing Economy International Inc.'>OTC:SEII</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a> <font color='red'>-8%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3372447\" data-linked=\"Midday Gainers / Losers (07/23/2018)\" data-tweet=\"$DDE $DDE $RETA - Midday Gainers / Losers (07/23/2018) https://seekingalpha.com/news/3372447-midday-gainers-losers-07-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3372447-midday-gainers-losers-07-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372439\" data-ts=\"1532363074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QEPC\" target=\"_blank\">QEPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372439-q-e-p-co-slides-11_9-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Q.E.P. Co slides 11.9% post Q1 results</a></h4><ul><li>Q.E.P. Co. (<a href='https://seekingalpha.com/symbol/QEPC' title='Q.E.P. Co., Inc.'>OTCPK:QEPC</a> <font color='red'>-11.9%</font>) <u><a href=\"https://seekingalpha.com/pr/17222530-q-e-p-co-inc-reports-first-quarter-2019-sales-earnings\" target=\"_blank\">reports Q1</a></u>&nbsp;revenue growth of 7.2% Y/Y to $87.9M.</li><li>Q1 overall margin: Gross&nbsp;<font color='red'>declined 110 bps</font>&nbsp;to 27.5%; Operating&nbsp;<font color='red'>declined 226 bps</font>&nbsp;to 2.5% &amp; Adj. EBITDA&nbsp;<font color='red'>declined 223 bps&nbsp;</font>to 3.75%.</li><li>Operating expenses was $22M (+12.8% Y/Y), the increase was due to acquisition and integration costs, higher freight costs &amp; marketing program spending in&nbsp;Australia.</li><li>CFO was $4.2M (+250% Y/Y) &amp; Working capital of $45.2M (-17.7% Y/Y).</li><li>Aggregate debt, net of available cash balance was $15.4M (+202% Y/Y), reflecting the use of cash to make strategic investments in the business.</li><li>&ldquo;We continue to invest resources in new acquisition searches. The overall business continues to experience cost pressures as product, manufacturing and shipping costs increase. QEP will look to offset and contain these costs where possible, as well as pursue market-based price increases when practical to maximize our earnings.&rdquo; said Lewis Gould, Chairman of the Board of Directors.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372320-q-e-p-reports-q1-results\" target=\"_blank\">Q.E.P. reports Q1 results</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372439\" data-linked=\"Q.E.P. Co slides 11.9% post Q1 results\" data-tweet=\"$QEPC - Q.E.P. Co slides 11.9% post Q1 results https://seekingalpha.com/news/3372439-q-e-p-co-slides-11_9-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3372439-q-e-p-co-slides-11_9-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372435\" data-ts=\"1532362344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372435-cleveland-cliffsplus-9-j-p-morgan-upgrades-street-high-15-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland-Cliffs +9% as J.P. Morgan upgrades with Street-high $15 target</a></h4><ul>     <li>Cleveland-Cliffs (<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+9.4%</font>) surges to a fresh 52-week high, extending Friday's 13% <a href=\"https://seekingalpha.com/news/3372010-cleveland-cliffs-plus-7-percent-strong-q2-results-improved-full-year-sales-view\" target=\"_blank\">post-earnings gains</a>, as J.P. Morgan <a href=\"https://thefly.com/thestreet/realmoney/index.php/CLFid2761685/CLF-ClevelandCliffs-upgraded-to-Overweight-from-Neutral-at-JPMorgan\" target=\"_blank\">upgrades</a> shares to Overweight from Neutral with a Street-high $15 price target.</li>     <li>JPM analyst Michael Gambardella cites CLF's strong U.S. iron ore earnings momentum and the removal of an overhang with the expected sale of Asia Pacific Iron Ore assets.</li>     <li>U.S. manufacturing and domestic steel market are experiencing robust activity, which is creating more demand for iron ore pellets and allowing CLF to increase its sales volume guidance and realized pricing  expectation, Gambardella writes.</li>     <li>Also, Citi analyst Daniel Knauff sees r<a href=\"https://thefly.com/thestreet/realmoney/index.php/CLFid2761766/CLF-ClevelandCliffs-shares-have-room-to-move-higher-says-Citi\" target=\"_blank\">oom for CLF to move higher</a> as the company delivers on deleveraging, begins capital returns and de-risks the HBI project the stock; Citi keeps a Buy rating and lifts its stock price target to $12 from $11.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372435\" data-linked=\"Cleveland-Cliffs +9% as J.P. Morgan upgrades with Street-high $15 target\" data-tweet=\"$CLF - Cleveland-Cliffs +9% as J.P. Morgan upgrades with Street-high $15 target https://seekingalpha.com/news/3372435-cleveland-cliffsplus-9-j-p-morgan-upgrades-street-high-15-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3372435-cleveland-cliffsplus-9-j-p-morgan-upgrades-street-high-15-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372433\" data-ts=\"1532361938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372433-glaxo-down-2-ahead-of-ad-com-review-of-mepolizumab-for-copd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glaxo down 2% ahead of Ad Com review of mepolizumab for COPD</a></h4><ul><li>GlaxoSmithKline (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='red'>-1.9%</font>) slips on average volume in apparent reaction to the release of briefing materials ahead of Wednesday's <a href=\"https://www.fda.gov/AdvisoryCommittees/Calendar/ucm610260.htm\" target=\"_blank\">meeting </a>of the FDA's Pulmonary-Allergy Drugs Advisory Committee during which it will review and discuss the company's marketing application seeking approval to use <a href=\"https://www.nucala.com/index.html\" target=\"_blank\">NUCALA</a> (mepolizumab) as add-on treatment to inhaled corticosteroids in patients with chronic obstructive pulmonary disease &#40;COPD&#41;.</li><li>The FDA's document states that the agency does not have regulatory experience with COPD therapies that target eosinophil count, adding that the lack of consensus related to the eosinophilic COPD phenotype \"creates challenges\" in defining the group of patients that could derive benefit from the IL-5 inhibitor.</li><li>Further, GSK did not conduct a proof-of-concept study or a dose-ranging study prior to its Phase 3 trials which evaluated a dose (100 mg every 4 weeks) selected from its severe asthma program.</li><li>Adding to the uncertainty is the mixed results from GSK's two Phase 3 COPD studies, one met the primary endpoint of a statistically significant reduction in the rate of moderate-to-severe COPD exacerbations and the other did not.</li><li>The FDA <a href=\"https://www.drugs.com/history/nucala.html\" target=\"_blank\">first approved</a> NUCALA in November 2015 for severe asthma.</li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM614138.pdf\" target=\"_blank\">FDA briefing doc&nbsp;</a></li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM614140.pdf\" target=\"_blank\">Errata to FDA briefing doc&nbsp;</a></li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM614141.pdf\" target=\"_blank\">GSK briefing doc&nbsp;</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3372433\" data-linked=\"Glaxo down 2% ahead of Ad Com review of mepolizumab for COPD\" data-tweet=\"$GSK - Glaxo down 2% ahead of Ad Com review of mepolizumab for COPD https://seekingalpha.com/news/3372433-glaxo-down-2-ahead-of-ad-com-review-of-mepolizumab-for-copd?source=tweet\" data-url=\"https://seekingalpha.com/news/3372433-glaxo-down-2-ahead-of-ad-com-review-of-mepolizumab-for-copd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372431\" data-ts=\"1532361633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAS\" target=\"_blank\">HAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372431-consumer-top-gainers-losers-of-12-00-pm-07-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (07/23/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372431\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (07/23/2018)\" data-tweet=\"$HAS $HAS $FAMI - Consumer - Top Gainers / Losers as of 12:00 PM (07/23/2018) https://seekingalpha.com/news/3372431-consumer-top-gainers-losers-of-12-00-pm-07-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3372431-consumer-top-gainers-losers-of-12-00-pm-07-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372422\" data-ts=\"1532360300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RWLK\" target=\"_blank\">RWLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372422-rewalk-robotics-retraces-from-expanded-va-access-stoked-rally-down-23\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReWalk Robotics retraces from expanded VA access-stoked rally; down 23%</a></h4><ul><li>Nano cap ReWalk Robotics (<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='red'>-23.2%</font>) is down on a 9x surge in volume, giving up a chunk of Friday's&nbsp;<font color='green'>74%</font>&nbsp;pop on the <a href=\"https://seekingalpha.com/pr/17221714-u-s-department-veterans-affairs-expands-access-rewalk-exoskeletons-paralyzed-veterans-revised\" target=\"_blank\">news </a>that the Veterans Administration &#40;VA&#41; revised its national policy on exoskeleton medical device training and procurement for veterans with spinal cord injury. The updated policy expands access to training program locations in the VA network and private rehab centers through the VA's Veterans Choice Program.</li><li>The company says there are currently 142 ReWalk-certified private and VA SCI/D training centers in the U.S. that can train veterans to use the ReWalk device.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372422\" data-linked=\"ReWalk Robotics retraces from expanded VA access-stoked rally; down 23%\" data-tweet=\"$RWLK - ReWalk Robotics retraces from expanded VA access-stoked rally; down 23% https://seekingalpha.com/news/3372422-rewalk-robotics-retraces-from-expanded-va-access-stoked-rally-down-23?source=tweet\" data-url=\"https://seekingalpha.com/news/3372422-rewalk-robotics-retraces-from-expanded-va-access-stoked-rally-down-23\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372418\" data-ts=\"1532359686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OASM\" target=\"_blank\">OASM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372418-oasmia-pharma-up-46-ahead-of-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oasmia Pharma up 46% ahead of equity offering</a></h4><ul><li>Ultra-thinly traded Oasmia Pharmaceutical AB (<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a> <font color='green'>+46.2%</font>) is up on more than a 12x surge in volume, albeit on turnover of only 149K shares, ahead of its planned <a href=\"https://www.sec.gov/Archives/edgar/data/1607245/000114420418023831/tv492228_f3.htm\" target=\"_blank\">$25M public equity offering</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372418\" data-linked=\"Oasmia Pharma up 46% ahead of equity offering\" data-tweet=\"$OASM - Oasmia Pharma up 46% ahead of equity offering https://seekingalpha.com/news/3372418-oasmia-pharma-up-46-ahead-of-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3372418-oasmia-pharma-up-46-ahead-of-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372413\" data-ts=\"1532358997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYPL\" target=\"_blank\">PYPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372413-paypal-square-stand-to-gain-from-snapcash-shutdown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PayPal, Square stand to gain from Snapcash shutdown</a></h4><ul><li>PayPal (<a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a> <font color='red'>-1.1%</font>) and Square (<a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a> <font color='green'>+1.1%</font>) both stand to profit from one fewer competitor in the peer-to-peer payment space, writes Credit Suisse Paul Condra in a note, according to Bloomberg.</li><li>Even though, Square partners with Snapchat (<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a> <font color='red'>-0.1%</font>) on Snapcash, Square is likely better off with fewer \"front-end\" P2P competitors; Square's own Cash App is a \"better play for them\" than the back-end work it's doing on Snap's service, Condra responded to Bloomberg.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372289-snap-shutting-snapcash-august-30\" target=\"_blank\">Snap shutting Snapcash on August 30</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372413\" data-linked=\"PayPal, Square stand to gain from Snapcash shutdown\" data-tweet=\"$PYPL $PYPL $SQ - PayPal, Square stand to gain from Snapcash shutdown https://seekingalpha.com/news/3372413-paypal-square-stand-to-gain-from-snapcash-shutdown?source=tweet\" data-url=\"https://seekingalpha.com/news/3372413-paypal-square-stand-to-gain-from-snapcash-shutdown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372412\" data-ts=\"1532358947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOLCF\" target=\"_blank\">SOLCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372412-scythian-bio-to-enter-cannabis-market-in-brazil-shares-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scythian Bio to enter cannabis market in Brazil; shares up 7%</a></h4><ul><li>Scythian Biosciences (SCCYF <font color='green'>+6.6%</font>) <a href=\"https://seekingalpha.com/pr/17222549-scythian-biosciences-corp-announces-strategic-partnership-cannabis-brazil-one-founders\" target=\"_blank\">inks a binding letter of intent </a>with to acquire 15% of Brazil Investments, the entity that will finalize the acquisition of 100% of the outstanding shares of Green Farma Brasil.</li><li>In exchange for the acquisition, Scythian will pay $2.4M in stock.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372412\" data-linked=\"Scythian Bio to enter cannabis market in Brazil; shares up 7%\" data-tweet=\"$SOLCF - Scythian Bio to enter cannabis market in Brazil; shares up 7% https://seekingalpha.com/news/3372412-scythian-bio-to-enter-cannabis-market-in-brazil-shares-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3372412-scythian-bio-to-enter-cannabis-market-in-brazil-shares-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372407\" data-ts=\"1532358063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXPI\" target=\"_blank\">NXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372407-nxpminus-2-ahead-of-wednesdays-qualcomm-deal-deadline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NXP -2% ahead of Wednesday&#39;s Qualcomm deal deadline</a></h4><ul><li>        NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>)&nbsp;<font color='red'>drops 2.1%</font>&nbsp;as the Wednesday <a href=\"https://www.wsj.com/articles/qualcomm-faces-demise-of-nxp-deal-as-u-s-china-trade-fight-rumbles-on-1532351897?mod=rss_Technology\" target=\"_blank\">deal deadline looms</a> for its acquisition by Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>).</li><li>               China is the last of nine markets that need to approve the deal, and the US-China trade tensions have put that approval in jeopardy.&nbsp;</li><li>               Antitrust regulators could still sign off, but that&rsquo;s not likely after President Trump&rsquo;s threat Friday to put tariffs on $500B in imports.&nbsp;</li><li>               If Qualcomm walks, NXP gets a $2B breakup fee.&nbsp;</li><li>               Qualcomm shares are&nbsp;<font color='red'>down 0.2%</font>.&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372099-qualcomm-extends-nxp-cash-tender-offer-final-time\" target=\"_blank\">Qualcomm extends its NXP cash tender offer for final time</a> (July 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372407\" data-linked=\"NXP -2% ahead of Wednesday&#39;s Qualcomm deal deadline\" data-tweet=\"$NXPI $NXPI $QCOM - NXP -2% ahead of Wednesday&#39;s Qualcomm deal deadline https://seekingalpha.com/news/3372407-nxpminus-2-ahead-of-wednesdays-qualcomm-deal-deadline?source=tweet\" data-url=\"https://seekingalpha.com/news/3372407-nxpminus-2-ahead-of-wednesdays-qualcomm-deal-deadline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372406\" data-ts=\"1532358043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OASM\" target=\"_blank\">OASM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372406-healthcare-top-5-gainers-losers-of-11-00-07-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/23/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/AMPE' title='Ampio Pharmaceuticals, Inc.'>AMPE</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CTXR' title='Citius Pharmaceuticals Inc.'>CTXR</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372406\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/23/2018)\" data-tweet=\"$OASM $OASM $LPNT - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/23/2018) https://seekingalpha.com/news/3372406-healthcare-top-5-gainers-losers-of-11-00-07-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3372406-healthcare-top-5-gainers-losers-of-11-00-07-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372405\" data-ts=\"1532357922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KWBT\" target=\"_blank\">KWBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372405-kiwa-bio-tech-updates-sales-guidance-for-1h18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kiwa Bio-Tech updates sales guidance for 1H18</a></h4><ul>     <li>Kiwa Bio-Tech (<a href='https://seekingalpha.com/symbol/KWBT' title='Kiwa Bio-Tech Products Group Corp.'>OTCPK:KWBT</a>) says that fertilizer sales reached 73.6K tons in the first two quarters ending June 30, 2018.  This sales amount is nearly equal to the total annual sales of 76,66K tons in 2017.</li><li><a href=\"https://seekingalpha.com/pr/17222434-kiwa-bio-tech-products-group-provides-guidance-sales-increase-first-half-2018\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3372405\" data-linked=\"Kiwa Bio-Tech updates sales guidance for 1H18\" data-tweet=\"$KWBT - Kiwa Bio-Tech updates sales guidance for 1H18 https://seekingalpha.com/news/3372405-kiwa-bio-tech-updates-sales-guidance-for-1h18?source=tweet\" data-url=\"https://seekingalpha.com/news/3372405-kiwa-bio-tech-updates-sales-guidance-for-1h18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372404\" data-ts=\"1532357686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLRN\" target=\"_blank\">XLRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372404-accelerons-aceminus-083-shows-positive-effect-in-mid-stage-study-in-inherited-neurological\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acceleron&#39;s ACE-083 shows positive effect in mid-stage study in inherited neurological disorder; shares up 2%</a></h4><ul><li>Acceleron Pharma (<a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a> <font color='green'>+1.6%</font>) is up on below-average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17222299-acceleron-announces-preliminary-results-part-1-aceminus-083-phase-2-trial-patients-charcot\" target=\"_blank\">announcement </a>of positive preliminary data from Part 1 of its two-part <a href=\"https://clinicaltrials.gov/ct2/show/NCT03124459?term=NCT03124459&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial </a>evaluating ACE-083 in patients with <a href=\"https://www.cmtausa.org/understanding-cmt/what-is-cmt/\" target=\"_blank\">Charcot-Marie-Tooth</a> &#40;CMT&#41; disease, an inherited neurological disorder characterized by the progressive loss of muscle tissue and touch sensation in the extremities. The results were presented at the Peripheral Nerve Society annual meeting in Baltimore, MD.</li><li>Data from Part 1, an open-label, dose-escalation study in 18 subjects, showed mean total muscle volume increases from 12.6 - 14.2%. Mean absolute improvements in fat fraction ranged from 1.7 - 3.5%.</li><li>Part 2 should be initiated this quarter. According to ClinicalTrials.gov, the estimated completion date is February 2020.</li><li><a href=\"http://acceleronpharma.com/product-candidates/ace-083/\" target=\"_blank\">ACE-083</a>&nbsp;binds to (inhibits) certain proteins in the TGF-beta superfamily that negatively regulate (reduce) muscle growth, including activins and myostatin.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372404\" data-linked=\"Acceleron&#39;s ACE-083 shows positive effect in mid-stage study in inherited neurological disorder; shares up 2%\" data-tweet=\"$XLRN - Acceleron&#39;s ACE-083 shows positive effect in mid-stage study in inherited neurological disorder; shares up 2% https://seekingalpha.com/news/3372404-accelerons-aceminus-083-shows-positive-effect-in-mid-stage-study-in-inherited-neurological?source=tweet\" data-url=\"https://seekingalpha.com/news/3372404-accelerons-aceminus-083-shows-positive-effect-in-mid-stage-study-in-inherited-neurological\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372401\" data-ts=\"1532357209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRNT\" target=\"_blank\">VRNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372401-reuters-verint-nso-merger-talks-end-without-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Verint, NSO merger talks end without deal</a></h4><ul><li>           Talks for Verint Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a>) to merge its security division with Israeli cyber surveillance company NSO Group for about $1B ended without a deal, according to <a href=\"https://www.reuters.com/article/us-verint-systems-m-a-nso/verint-merger-talks-with-israels-nso-group-terminated-source-idUSKBN1KD15G\" target=\"_blank\">Reuters sources</a>. </li><li> The source didn&rsquo;t disclose why the talks ended. </li><li>           Verint shares are&nbsp;<font color='red'>down 0.8%</font>&nbsp;to $47.95.&nbsp; &nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3372401\" data-linked=\"Reuters: Verint, NSO merger talks end without deal\" data-tweet=\"$VRNT - Reuters: Verint, NSO merger talks end without deal https://seekingalpha.com/news/3372401-reuters-verint-nso-merger-talks-end-without-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3372401-reuters-verint-nso-merger-talks-end-without-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372398\" data-ts=\"1532357053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WING\" target=\"_blank\">WING</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372398-wells-fargo-confident-on-wingstop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo confident on Wingstop</a></h4><ul> <li>Wells Fargo expects a strong Q2 to be turned in by Wingstop (<a href='https://seekingalpha.com/symbol/WING' title='Wingstop, Inc.'>WING</a> <font color='green'>+0.7%</font>) after brand penetration helped to improve the restaurant chain's traffic.</li> <li>The investment firm keeps an Outperform rating on WING and takes its price target to $60.</li> <li>The boost in confidence from Wells arrives with Wingstop already up 35% YTD.</li> <li>Wingstop reports earnings on August 2.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3372398\" data-linked=\"Wells Fargo confident on Wingstop\" data-tweet=\"$WING - Wells Fargo confident on Wingstop https://seekingalpha.com/news/3372398-wells-fargo-confident-on-wingstop?source=tweet\" data-url=\"https://seekingalpha.com/news/3372398-wells-fargo-confident-on-wingstop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372390\" data-ts=\"1532355952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LCII\" target=\"_blank\">LCII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372390-rv-sector-in-reverse-on-shipments-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RV sector in reverse on shipments concerns</a></h4><ul> <li>RV stocks are trading lower after CL King warns that an industry-wide projection for 7% RV shipments growth this year will be hard to achieve.</li> <li>Analyst Scott Stember thinks the influential RV Industry Association could reset its 2018 shipment projection to 515K-520K from 540K at the important Open House event in September.</li><li>LCI Industries (NYSE:<a href='https://seekingalpha.com/symbol/LCII' title='LCI Industries'>LCII</a>) is <font color='red'>down 3.23%</font>, while Thor Industries (NYSE:<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a>) is <font color='red'>off 2.49%</font> and Winnebago (NYSE:<a href='https://seekingalpha.com/symbol/WGO' title='Winnebago Industries, Inc.'>WGO</a>) <font color='red'>peels off 1.68%</font>.</li> <li>The expectation for lower shipments is also impacting Camping World Holdings (<a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a> <font color='red'>-2.6%</font>).</li> <li>Sources: CNBC, Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372390\" data-linked=\"RV sector in reverse on shipments concerns\" data-tweet=\"$LCII $LCII $THO - RV sector in reverse on shipments concerns https://seekingalpha.com/news/3372390-rv-sector-in-reverse-on-shipments-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3372390-rv-sector-in-reverse-on-shipments-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372389\" data-ts=\"1532355898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372389-oil-service-stocks-drop-halliburtons-q2-fails-to-calm-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil service stocks drop as Halliburton&#39;s Q2 fails to calm concerns</a></h4><ul>     <li>Oil service stocks are dropping amid Halliburton&rsquo;s (<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='red'>-8.3%</font>) Q2 earnings  conference call, as the company comments on Permian bottlenecks, pricing and  temporary softness in the Marcellus Shale.</li>     <li>HAL, which fell slightly in premarket trading after reporting <a href=\"https://seekingalpha.com/news/3372306-halliburton-slips-line-q2-results\" target=\"_blank\">in-line Q2 results</a>, has plunged as much as 8% after the opening bell, the most intraday since August 2015; other sector losers include <a href='https://seekingalpha.com/symbol/RES' title='RPC Inc.'>RES</a> <font color='red'>-6.9%</font>, <a href='https://seekingalpha.com/symbol/PTEN' title='Patterson-UTI Energy, Inc.'>PTEN</a> <font color='red'>-4.6%</font>, <a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a> <font color='red'>-3.4%</font>, <a href='https://seekingalpha.com/symbol/PKD-OLD' title='Parker Drilling Company'>PKD-OLD</a> <font color='red'>-3.1%</font>, <a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a> <font color='red'>-3%</font>, <a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color='red'>-2%</font>, <a href='https://seekingalpha.com/symbol/HP' title='Helmerich & Payne Inc.'>HP</a> <font color='red'>-1.5%</font>, <a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color='red'>-1.3%</font>.</li>     <li>Societe General's Edward Muztafago says HAL's Q2 is less about the earnings number and more about <a href=\"https://www.reuters.com/article/us-halliburton-results/halliburton-revenue-beats-on-strong-north-american-activity-idUSKBN1KD1AI\" target=\"_blank\">worries over transportation constraints</a> in the Permian Basin.</li><li>Wells Fargo&rsquo;s Jud Bailey says investor expected a strong Q2 beat, adding that HAL&rsquo;s outlook for  North American activity and margins in H2 2018 is critical; the firm sees the outlook \"likely to soften given the recent weakness in  pressure pumping supply/demand fundamentals.\" (Briefing.com)</li><li>HAL&nbsp;CEO Jeff Miller in the conference call, on concerns about transporation bottlenecks in the Permian Basin: \"In some ways, we're a victim of our own success, as we develop longer  laterals with better production. As a result, we expect this area to  have temporary softness in the back half of 2018, but it's poised to  regain activity as a calendar turns to 2019 and additional pipeline  capacity is available... I expect that these temporary efficiency drags will create headwinds for additional upward pricing\" in Q3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372389\" data-linked=\"Oil service stocks drop as Halliburton&#39;s Q2 fails to calm concerns\" data-tweet=\"$HAL $HAL $RES - Oil service stocks drop as Halliburton&#39;s Q2 fails to calm concerns https://seekingalpha.com/news/3372389-oil-service-stocks-drop-halliburtons-q2-fails-to-calm-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3372389-oil-service-stocks-drop-halliburtons-q2-fails-to-calm-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372377\" data-ts=\"1532355648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LECO\" target=\"_blank\">LECO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372377-on-lincoln-electrics-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Lincoln Electric&#39;s Q2 results</a></h4><ul><li>Lincoln Electric (<a href='https://seekingalpha.com/symbol/LECO' title='Lincoln Electric Holdings, Inc.'>LECO</a> <font color='red'>-1.1%</font>) reported Q2 sales growth of 26% Y/Y to $790.05M with a 9.3% Y/Y increase in organic sales and reflecting +16% benefit from acquisitions, +4.2% increase in price, +4.4% higher volumes and +0.7% forex.</li><li>Segment sales: Americas welding $426.51M (+14.2% Y/Y), International welding $243.37M (+72% Y/Y) due to contribution from acquisitions and The Harris product group $84.16M (+4.9% Y/Y).</li><li>Q2 Overall margins: Gross&nbsp;<font color='red'>declined by 32 bps</font>&nbsp;to 34.2%; operating&nbsp;<font color='red'>declined by 170 bps</font>&nbsp;to 12% and Adj. EBIT margin&nbsp;<font color='red'>declined by 82 bps</font>&nbsp;to 14.1%.</li><li>Q2 Adjusted operating income was $107M (+18.8% Y/Y) and margin was&nbsp;<font color='red'>down&nbsp;by 90 bps&nbsp;</font>to 13.3%. The Air Liquide Welding acquisition had an unfavorable impact of ~120 bps on the margin.</li><li>Adj. EPS increased by 25.8% Y/Y to $1.22 and ROIC<font color='green'> improved by 200 bps</font>&nbsp;to 18%.</li><li>Average operating working capital to net sales was 16.5% and total debt to invested capital was 42.7% as of June 30, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372268-lincoln-electric-eps-line-misses-revenue\" target=\"_blank\">Lincoln Electric EPS in-line, misses on revenue</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372377\" data-linked=\"More on Lincoln Electric&#39;s Q2 results\" data-tweet=\"$LECO - More on Lincoln Electric&#39;s Q2 results https://seekingalpha.com/news/3372377-on-lincoln-electrics-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3372377-on-lincoln-electrics-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372387\" data-ts=\"1532355582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPOP\" target=\"_blank\">BPOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372387-popular-authorized-stock-repurchase-of-125m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Popular authorized stock repurchase of $125M</a></h4><ul>     <li>Popular (NASDAQ:<a href='https://seekingalpha.com/symbol/BPOP' title='Popular, Inc.'>BPOP</a>) announced a common stock repurchase of up to $125M.</li><li>Shares&nbsp;<font color='green'>+6.1%.</font></li><li><a href=\"https://seekingalpha.com/pr/17222729-popular-announces-125-million-common-stock-repurchase-plan\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3372387\" data-linked=\"Popular authorized stock repurchase of $125M\" data-tweet=\"$BPOP - Popular authorized stock repurchase of $125M https://seekingalpha.com/news/3372387-popular-authorized-stock-repurchase-of-125m?source=tweet\" data-url=\"https://seekingalpha.com/news/3372387-popular-authorized-stock-repurchase-of-125m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372386\" data-ts=\"1532355527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHIL\" target=\"_blank\">PHIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372386-phi-group-spikes-31-after-deal-to-form-jv-for-offshore-blockchain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PHI Group spikes 31% after deal to form JV for offshore blockchain</a></h4><ul><li>PHI Group (<a href='https://seekingalpha.com/symbol/PHIL' title='PHI Group, Inc.'>OTCPK:PHIL</a>)&nbsp;<font color='green'>+31%</font>&nbsp;after agreeing to form a joint venture with Regent Blockchain Group to develop and operate an offshore financial center and blockchain businesses--including, but not limited to, apps, initial coin offerings, and cryptocurrency exchanges.</li><li>With the stock only at about 2 cents a share, any move in the price is a big move.</li><li>Some 1.02M PHIL shares changed hands in morning trading compared with the three-month daily average volume of 1.15M.</li><li>The JV will be located in the Cagayan Economic Zone in the Philippines.</li><li>PHI Group will contribute $4M in cash and/or preferred stock for a 51% stake and management rights of the venture. Regent Blockchain will contribute a sublicense of the financial technology solutions and offshore virtual currency license from the Philippine government.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17222528-b-phi-b-b-group-b-acquire-51-percent-joint-venture-filipino-regent-blockchain-b-group-b\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3369283-phi-group-partners-fintech-green-investment-company\" target=\"_blank\">PHI Group partners with Fintech Green Investment company</a> (July 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372386\" data-linked=\"PHI Group spikes 31% after deal to form JV for offshore blockchain\" data-tweet=\"$PHIL - PHI Group spikes 31% after deal to form JV for offshore blockchain https://seekingalpha.com/news/3372386-phi-group-spikes-31-after-deal-to-form-jv-for-offshore-blockchain?source=tweet\" data-url=\"https://seekingalpha.com/news/3372386-phi-group-spikes-31-after-deal-to-form-jv-for-offshore-blockchain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372373\" data-ts=\"1532354517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONB\" target=\"_blank\">ONB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372373-old-national-gains-after-q2-reflects-strong-commercial-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Old National gains after Q2 reflects strong commercial production</a></h4><ul><li>Old National Bancorp (NYSE:<a href='https://seekingalpha.com/symbol/ONB' title='Old National Bancorp'>ONB</a>)<font color='green'> rises 2.9%</font>&nbsp;after Q2 EPS and revenue beat consensus estimates.</li><li>Q2 results reflected increased interest rates, disciplined expense management, and record commercial production, said CEO Bob Jones.</li><li>Net interest margin on fully taxable equivalent basis was 3.55% vs. 3.45% in Q1 and 3.42% a year ago.</li><li>Adjusted noninterest expense was $114.5M vs. $111.3M in Q1.</li><li>End-of-period commercial and industrial loans were $2.96B compared to $2.81B; 21.5% annualized growth.</li><li>Tier 1 common equity 10.9% at June 30, 2018 vs. 10.7% at March 30, 2018 and 11.5% at June 30, 2017.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17222272-old-national-reports-2nd-quarter-net-income-44_0-million-13_2-percent-increase-year-ago\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3372235-old-national-bancorp-beats-0_03-beats-revenue\" target=\"_blank\">Old National Bancorp beats by $0.03, beats on revenue</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372373\" data-linked=\"Old National gains after Q2 reflects strong commercial production\" data-tweet=\"$ONB - Old National gains after Q2 reflects strong commercial production https://seekingalpha.com/news/3372373-old-national-gains-after-q2-reflects-strong-commercial-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3372373-old-national-gains-after-q2-reflects-strong-commercial-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372371\" data-ts=\"1532354370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372371-amazonminus-1_5-president-trump-tweets-post-office-washington-post\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon -1.5% as President Trump tweets about Post Office, Washington Post</a></h4><ul><li>        Amazon&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) on the move after some tweets from President Trump.</li><li>               <a href=\"https://twitter.com/realDonaldTrump/status/1021384752136409088\" target=\"_blank\">First tweet</a>: &ldquo;The Amazon Washington Post has gone crazy against me ever since they lost the Internet Tax Case in the U.S. Supreme Court two months ago. Next up is the U.S. Post Office which they use, at a fraction of real cost, as their &ldquo;delivery boy&rdquo; for a BIG percentage of their packages&hellip;.&rdquo;&nbsp;</li><li>               Trump slammed the Postal Service late last year for undercharging Amazon for deliveries, which he claimed cost the service money. The Postal Service&rsquo;s FY17 results had revenue down $1.8B on the year due to declines in First-Class and Marketing Mail, partially offset by a growth in package volume.</li><li>               Last month&rsquo;s Supreme Court ruling pertaining to online sales taxes actually benefitted Amazon. The company already collected sales tax on the product it sells directly and the ruling didn&rsquo;t specify how third-party sales should be taxed.&nbsp;</li><li>               <a href=\"https://twitter.com/realDonaldTrump/status/1021388295618682881\" target=\"_blank\">Second tweet</a>: &ldquo;&hellip;.In my opinion the Washington Post is nothing more than an expensive (the paper loses a fortune) lobbyist for Amazon. Is it used as protection against antitrust claims which many feel should be brought?&rdquo;&nbsp;</li><li>               The Washington Post is owned by Jeff Bezos&rsquo; holding company Nash Holdings, not Amazon itself.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='red'>down 1.5%</font>&nbsp;to $1,787.32.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320429-trump-slams-amazon-calling-higher-post-office-pricing\" target=\"_blank\">Trump slams Amazon while calling for higher Post Office pricing</a> (Dec. 29, 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365562-online-retail-rattled-supreme-court-ruling\" target=\"_blank\">Online retail rattled by Supreme Court ruling</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372371\" data-linked=\"Amazon -1.5% as President Trump tweets about Post Office, Washington Post\" data-tweet=\"$AMZN - Amazon -1.5% as President Trump tweets about Post Office, Washington Post https://seekingalpha.com/news/3372371-amazonminus-1_5-president-trump-tweets-post-office-washington-post?source=tweet\" data-url=\"https://seekingalpha.com/news/3372371-amazonminus-1_5-president-trump-tweets-post-office-washington-post\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>102&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372364\" data-ts=\"1532353677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SALT\" target=\"_blank\">SALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372364-scorpio-bulkers-lower-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scorpio Bulkers lower after earnings</a></h4><ul> <li>Scorpio Bulkers (NYSE:<a href='https://seekingalpha.com/symbol/SALT' title='Scorpio Bulkers Inc'>SALT</a>) trades <font color='red'>down 1.04%</font> after the company misses <a href=\"https://seekingalpha.com/pr/17222369-scorpio-bulkers-inc-announces-financial-results-second-quarter-2018-declares-quarterly\" target=\"_blank\">Q2</a> estimates.</li> <li>The company says its Kamsarmax fleet earned $12,823 per day during the quarter and the Ultramax fleet earned $11,569 per day.</li> <li>For voyages fixed for Q3,,the Kamsarmax fleet is at approximately $13,974 per day for 47% of the day and the Ultramax fleet is at approximately $10,963 per day for 46% of the days.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372274-scorpio-bulkers-misses-0_02-misses-revenue\" target=\"_blank\">Scorpio Bulkers misses by $0.02, misses on revenue</a> (July 23)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3372364\" data-linked=\"Scorpio Bulkers lower after earnings\" data-tweet=\"$SALT - Scorpio Bulkers lower after earnings https://seekingalpha.com/news/3372364-scorpio-bulkers-lower-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3372364-scorpio-bulkers-lower-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372357\" data-ts=\"1532352660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372357-citi-bullish-on-tenet-sees-29-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi bullish on Tenet, sees 29% upside</a></h4><ul><li>Citigroup's Ralph Giacobbe is Tenet Healthcare's (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+4.8%</font>) head cheerleader, boosting his price target to a Street-high $44 (29% upside) citing more upside from margin improvement and more opportunity for additional savings.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3372357\" data-linked=\"Citi bullish on Tenet, sees 29% upside\" data-tweet=\"$THC - Citi bullish on Tenet, sees 29% upside https://seekingalpha.com/news/3372357-citi-bullish-on-tenet-sees-29-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3372357-citi-bullish-on-tenet-sees-29-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372355\" data-ts=\"1532352477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLPH\" target=\"_blank\">DLPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372355-oppenheimer-sees-bounceback-for-delphi-technologies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer sees bounceback for Delphi Technologies</a></h4><ul> <li>Oppenheimer upgrades Delphi Technologies (NYSE:<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a>) to an Outperform rating after watching shares fall 15% in just over a month.</li> <li>\"Trade risks, peak US SAAR concerns, light duty diesel decline and potential long-term disruption from electrification have all contributed to a tempest of negative sentiment on the auto suppliers. However, in our view, fundamentals have not meaningfully deteriorated for Delphi and we are raising our estimates for FY18 organic and total sales growth,\" reads the Oppenheimer note.</li> <li>The firm assigns a price target of $53 on DLPH to rep 18% upside potential.</li> <li>DLPH <font color='green'>+1.07%</font> premarket to $45.30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372355\" data-linked=\"Oppenheimer sees bounceback for Delphi Technologies\" data-tweet=\"$DLPH - Oppenheimer sees bounceback for Delphi Technologies https://seekingalpha.com/news/3372355-oppenheimer-sees-bounceback-for-delphi-technologies?source=tweet\" data-url=\"https://seekingalpha.com/news/3372355-oppenheimer-sees-bounceback-for-delphi-technologies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372352\" data-ts=\"1532352377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372352-seven-stars-cloud-in-exclusive-deal-on-fixed-income-products\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seven Stars Cloud in exclusive deal on fixed-income products</a></h4><ul>   <li>Seven Stars Cloud (NASDAQ:<a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>) has reahced an <a href=\"https://seekingalpha.com/pr/17222684-seven-stars-cloud-announces-agreement-china-venture-capital-research-institute-exclusively\" target=\"_blank\">exclusive deal</a> with the China Venture Capital Research Institute to provide new fixed-income products to financial markets.</li>    <li>Shares are <font color='green'>up 6.8%</font> premarket.</li>    <li>The deal calls for SSC to offer fintech services including fractionalization and securitization in China for new fixed-income classes; regulated products and assets on exchanges outside of China (including the Delaware Board of Trade), and tokenization of the asset classes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372352\" data-linked=\"Seven Stars Cloud in exclusive deal on fixed-income products\" data-tweet=\"$SSC-OLD - Seven Stars Cloud in exclusive deal on fixed-income products https://seekingalpha.com/news/3372352-seven-stars-cloud-in-exclusive-deal-on-fixed-income-products?source=tweet\" data-url=\"https://seekingalpha.com/news/3372352-seven-stars-cloud-in-exclusive-deal-on-fixed-income-products\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372346\" data-ts=\"1532351921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372346-exxon-hess-raise-stabroek-resource-estimate-25-to-4b-boe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exxon, Hess raise Stabroek resource estimate by 25% to 4B boe</a></h4><ul>     <li>Exxon Mobil (NYSE:<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a>) and Hess (NYSE:<a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a>) say they now expect the Stabroek oil block offshore Guyana to <a href=\"http://news.exxonmobil.com/press-release/exxonmobil-increases-estimate-guyanas-stabroek-block-4-billion-barrels\" target=\"_blank\">contain ~25% more recoverable resources</a> than previously estimated.</li>     <li>The project partners raise their estimate of       gross discovered recoverable resources for the Stabroek Block, part of one of the world's biggest oil discoveries in the last decade, to more than 4B boe, up from the previous estimate of 3.2B boe.</li>     <li>The increase follows completion of testing at the Liza-5 appraisal well, a discovery at Ranger, incorporation of results from the eighth discovery on the Block at the Longtail exploration well into the Turbot area evaluation, and completion of the Pacora discovery evaluation.</li>     <li>The companies say the evaluation supports a third phase of development and consideration of two additional phases; the collective discoveries at Stabroek to date have established the potential for as many as five FPSO vessels producing more than 750K bbl/day by 2025.</li>     <li>XOM owns a 45% interest in the Stabroek Block, Hess        holds 30% and Cnooc's (NYSE:<a href='https://seekingalpha.com/symbol/CEO' title='CNOOC Limited'>CEO</a>) Nexen Petroleum has a 25% stake; HES&nbsp;<font color='green'>+3%</font>, XOM <font color='green'>+0.5%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372346\" data-linked=\"Exxon, Hess raise Stabroek resource estimate by 25% to 4B boe\" data-tweet=\"$XOM $XOM $HES - Exxon, Hess raise Stabroek resource estimate by 25% to 4B boe https://seekingalpha.com/news/3372346-exxon-hess-raise-stabroek-resource-estimate-25-to-4b-boe?source=tweet\" data-url=\"https://seekingalpha.com/news/3372346-exxon-hess-raise-stabroek-resource-estimate-25-to-4b-boe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372339\" data-ts=\"1532351471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWBI\" target=\"_blank\">NWBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372339-northwest-bancshares-eps-in-line-beats-on-net-interest-income\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northwest Bancshares EPS in-line, beats on net interest income</a></h4><ul><li>Northwest Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/NWBI' title='Northwest Bancshares, Inc.'>NWBI</a>): Q2 EPS of $0.25 in-line.</li><li>Net interest income of $84.23M (+1.8% Y/Y) <font color='green'>beats by $1.46M</font>.</li><li>Shares <font color='green'>+1.51%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17222654-northwest-bancshares-inc-announces-second-quarter-2018-earnings-quarterly-dividend\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3372339\" data-linked=\"Northwest Bancshares EPS in-line, beats on net interest income\" data-tweet=\"$NWBI - Northwest Bancshares EPS in-line, beats on net interest income https://seekingalpha.com/news/3372339-northwest-bancshares-eps-in-line-beats-on-net-interest-income?source=tweet\" data-url=\"https://seekingalpha.com/news/3372339-northwest-bancshares-eps-in-line-beats-on-net-interest-income\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372338\" data-ts=\"1532351457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDE\" target=\"_blank\">DDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372338-premarket-gainers-of-9-05-07-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (07/23/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/DDE' title='Dover Downs Gaming & Entertainment, Inc.'>DDE</a> <font color='green'>+49%</font>&nbsp;on new casino <a href=\"https://seekingalpha.com/news/3372326-dover-downs-pops-new-casino-deal\" target=\"_blank\">deal</a>.</li>     <li><a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <font color='green'>+34%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3372261-lifepoint-health-merge-rcch-healthcare-partners-65-share-shares-34-percent-premarket\" target=\"_blank\">merge</a> with RCCH HealthCare Partners at $65/share.</li>     <li><a href='https://seekingalpha.com/symbol/BRN' title='Barnwell Industries, Inc'>BRN</a> <font color='green'>+27%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3372226-barnwell-industries-inks-agreement-purchase-canadian-oil-gas-assets\" target=\"_blank\">agreement</a> for the purchase of Canadian Oil and Gas Assets.</li>     <li><a href='https://seekingalpha.com/symbol/HCLP' title='Hi-Crush Partners LP'>HCLP</a> <font color='green'>+19%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3372286-hi-crush-plus-12-percent-hiking-distribution-potential-conversion-c-corp\" target=\"_blank\">after</a> hiking distribution, potential conversion to C-Corp.</li>     <li><a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a> <font color='green'>+12%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3372234-hasbro-beats-0_18-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/JMEI' title='Jumei International Holding Limited'>JMEI</a> <font color='green'>+11%</font>&nbsp;on buyback <a href=\"https://seekingalpha.com/news/3372263-jumei-updates-buyback-activity\" target=\"_blank\">activity</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='green'>+7%</font>&nbsp;on LifePoint <a href=\"https://seekingalpha.com/news/3372266-community-health-9-percent-premarket-lifepoint-deal\" target=\"_blank\">deal</a>.</li>     <li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372338\" data-linked=\"Premarket Gainers as of 9:05 am (07/23/2018)\" data-tweet=\"$DDE $DDE $LPNT - Premarket Gainers as of 9:05 am (07/23/2018) https://seekingalpha.com/news/3372338-premarket-gainers-of-9-05-07-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3372338-premarket-gainers-of-9-05-07-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372337\" data-ts=\"1532351374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RWLK\" target=\"_blank\">RWLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372337-premarket-losers-of-9-05-7-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (7/23/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a>&nbsp;<font color='red'>-14%</font>.</li><li><a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a>&nbsp;<font color='red'>-14%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3372295-petmed-express-misses-0_01-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a> <font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17222339-redhill-biopharma-announces-uplisting-nasdaq-global-market\" target=\"_blank\">announcing</a> uplisting to Nasdaq.</li><li><a href='https://seekingalpha.com/symbol/ITW' title='Illinois Tool Works Inc.'>ITW</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3372297-illinois-tool-works-eps-line-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/RACE' title='Ferrari N.V.'>RACE</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372337\" data-linked=\"Premarket Losers as of 9:05 am (7/23/2018)\" data-tweet=\"$RWLK $RWLK $PETS - Premarket Losers as of 9:05 am (7/23/2018) https://seekingalpha.com/news/3372337-premarket-losers-of-9-05-7-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3372337-premarket-losers-of-9-05-7-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372326\" data-ts=\"1532350335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDE\" target=\"_blank\">DDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372326-dover-downs-pops-after-new-casino-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dover Downs pops after new casino deal</a></h4><ul> <li>Dover Downs Gaming &amp; Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/DDE' title='Dover Downs Gaming & Entertainment, Inc.'>DDE</a>) announces that it signed a deal to merge with&nbsp;Twin River Worldwide Holding.</li>     <li>Under the terms of the deal, Dover Downs stockholders will exchange       their Dover Downs shares for Twin River common shares representing 7.225%       of the equity in the combined company at closing.</li>     <li>Twin River reported revenue of $429M and adjusted EBITDA of $167M last year.</li><li>Shares of Dover Downs are&nbsp;<font color='green'>up 53%</font>&nbsp;in premarket trading.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17222168-dover-downs-gaming-and-entertainment-inc-combine-twin-river-worldwide-holdings-inc\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3372326\" data-linked=\"Dover Downs pops after new casino deal\" data-tweet=\"$DDE - Dover Downs pops after new casino deal https://seekingalpha.com/news/3372326-dover-downs-pops-after-new-casino-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3372326-dover-downs-pops-after-new-casino-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372324\" data-ts=\"1532350212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPOP\" target=\"_blank\">BPOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372324-popular-q2-reflects-gains-from-ending-fdic-shared-loss-pacts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Popular Q2 reflects gains from ending FDIC shared-loss pacts</a></h4><ul><li>Popular (NASDAQ:<a href='https://seekingalpha.com/symbol/BPOP' title='Popular, Inc.'>BPOP</a>) posts net income of $279.8M, including a $49.6M gain related to ending its FDIC shared-loss agreements and a related income tax benefit of $108.9M</li><li>Subtracting effects of early termination of FDIC shared-loss agreements and tax closing agreement results in adjusted net income of $121.3M.</li><li>That compares with year-ago net income of $91.M.</li><li>BPOP&nbsp;<font color='green'>+2%</font>&nbsp;in premarket trading of 481 shares.</li><li>Q2 net interest margin of 3.81% slips from 3.89% in Q1 and 4.02% a year ago.</li><li>Return on average common equity 20.8% vs 7.1% in Q1 and 7.24% a year ago.</li><li>Provision for loan losses $60.1M vs $69.3M in Q1 and $50M a year ago.</li><li>Common equity tier 1 capital ratio 17.5% vs 16.8% in Q1 and 16.7% a year ago.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17222418-popular-inc-announces-second-quarter-2018-financial-results\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3372302-popular-eps-2_73\" target=\"_blank\">Popular EPS of $2.73</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372324\" data-linked=\"Popular Q2 reflects gains from ending FDIC shared-loss pacts\" data-tweet=\"$BPOP - Popular Q2 reflects gains from ending FDIC shared-loss pacts https://seekingalpha.com/news/3372324-popular-q2-reflects-gains-from-ending-fdic-shared-loss-pacts?source=tweet\" data-url=\"https://seekingalpha.com/news/3372324-popular-q2-reflects-gains-from-ending-fdic-shared-loss-pacts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372321\" data-ts=\"1532349945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GST\" target=\"_blank\">GST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372321-gastar-explorationminus-28-restructuring-talk-heats-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gastar Exploration -28% as restructuring talk heats up</a></h4><ul>     <li>Gastar Exploration (NYSEMKT:<a href='https://seekingalpha.com/symbol/GST' title='Gastar Exploration Inc.'>GST</a>) <font color='red'>-27.9%</font> premarket after saying it hired Perella Weinberg Partners to advise the company in analyzing and evaluating financial and strategic alternatives, including a <a href=\"https://www.sec.gov/Archives/edgar/data/1431372/000156459018017085/gst-8k_20180720.htm\" target=\"_blank\">potential restructuring</a> of the company&rsquo;s balance sheet.</li>     <li>Also, the Ares investor group delivered a non-binding preliminary term sheet proposing that GST consider a sale of the company  or other potential restructuring transaction.</li>     <li>Ronald Scott and Nathan Walton resigned from the company's board.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3372321\" data-linked=\"Gastar Exploration -28% as restructuring talk heats up\" data-tweet=\"$GST - Gastar Exploration -28% as restructuring talk heats up https://seekingalpha.com/news/3372321-gastar-explorationminus-28-restructuring-talk-heats-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3372321-gastar-explorationminus-28-restructuring-talk-heats-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>193&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372318\" data-ts=\"1532349674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPTX\" target=\"_blank\">LPTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372318-leap-therapeutics-teams-up-merck-kgaa-and-pfizer-to-evaluate-combo-cancer-treatment-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leap Therapeutics teams up with Merck KGaA and Pfizer to evaluate combo cancer treatment; shares up 6% premarket</a></h4><ul><li>Thinly traded micro cap Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17222355-leap-therapeutics-announces-collaboration-merck-kgaa-darmstadt-germany-pfizer-evaluate\" target=\"_blank\">announced collaboration</a> with Merck KGaA (<a href='https://seekingalpha.com/symbol/MKGAY' title='Merck KGaA ADR'>OTCPK:MKGAY</a>) and Pfizer (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) to evaluate the combination of TRX518, Bavencio (avelumab) and chemo in patients with solid tumors.</li><li>Under the terms of the collaboration, Leap will conduct a Phase 1/2 study in patients with advanced solid tumors. Enrollment will commence in Q1 2019.</li><li><a href=\"https://www.leaptx.com/science/#immuno-oncology\" target=\"_blank\">TRX518&nbsp;</a>is a humanized monoclonal antibody that binds to the glucocorticoid-inducible TNF-superfamily receptor &#40;GITR&#41;. It is believed to enhance the immune system's anti-tumor response.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372318\" data-linked=\"Leap Therapeutics teams up with Merck KGaA and Pfizer to evaluate combo cancer treatment; shares up 6% premarket\" data-tweet=\"$LPTX $LPTX $MKGAY - Leap Therapeutics teams up with Merck KGaA and Pfizer to evaluate combo cancer treatment; shares up 6% premarket https://seekingalpha.com/news/3372318-leap-therapeutics-teams-up-merck-kgaa-and-pfizer-to-evaluate-combo-cancer-treatment-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3372318-leap-therapeutics-teams-up-merck-kgaa-and-pfizer-to-evaluate-combo-cancer-treatment-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372316\" data-ts=\"1532349480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LII\" target=\"_blank\">LII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372316-lennox-raised-fy2018-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lennox raised FY2018 guidance</a></h4><ul><li>Lennox (NYSE:<a href='https://seekingalpha.com/symbol/LII' title='Lennox International Inc.'>LII</a>) reports revenue rose 9% on constant currency basis in <a href=\"https://seekingalpha.com/pr/17222439-lennox-international-reports-record-revenue-profit-second-quarter\" target=\"_blank\">Q2</a>.</li><li>Residential Heating &amp; Cooling segment revenue up 10% to $716M.</li><li>Commercial Heating &amp; Cooling segment revenue grew 13% to $292M.</li><li>Refrigeration segment revenue increased 2% to $150M.</li><li>Adjusted gross margin rate slipped 70 bps to 30.8%.</li><li>Total segment margin expanded 50 bps to 17.8%.</li><li><b>FY2018 Guidance</b>: Revenue: +4% to +6%; Adjusted EPS: $9.95 to $10.35; GAAP EPS: $9.43 to $9.83; Tax rate: 22% to 24%; Share count: ~41M; Capex: ~$100M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372292-lennox-beats-0_11-beats-revenue\" target=\"_blank\">Lennox beats by $0.11, beats on revenue</a> (July 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3372316\" data-linked=\"Lennox raised FY2018 guidance\" data-tweet=\"$LII - Lennox raised FY2018 guidance https://seekingalpha.com/news/3372316-lennox-raised-fy2018-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3372316-lennox-raised-fy2018-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372310\" data-ts=\"1532348489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PM\" target=\"_blank\">PM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372310-societe-generale-negative-on-philip-morris\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Societe Generale negative on Philip Morris</a></h4><ul> <li>Societe Generale downgrades Philip Morris International (NYSE:<a href='https://seekingalpha.com/symbol/PM' title='Philip Morris International Inc.'>PM</a>) to a Hold rating from Buy on <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Societe+Generale+Downgrades+Philip+Morris+%28PM%29+to+Hold/14420887.html\" target=\"_blank\">concerns</a> over the introduction by the company of reduced risk products.</li><li>The French firm lowers its price target to $90 from $100.</li> <li>Shares of Philip Morris are <font color='red'>down 0.70%</font> in premarket trading to $83.72 vs. a 52-week trading range of $76.21 to $120.00.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3372310\" data-linked=\"Societe Generale negative on Philip Morris\" data-tweet=\"$PM - Societe Generale negative on Philip Morris https://seekingalpha.com/news/3372310-societe-generale-negative-on-philip-morris?source=tweet\" data-url=\"https://seekingalpha.com/news/3372310-societe-generale-negative-on-philip-morris\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372307\" data-ts=\"1532348371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372307-sangamo-therapeutics-to-acquire-txcell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo Therapeutics to acquire TxCell</a></h4><ul> <li>Sangamo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>) and TxCell S.A. (<a href='https://seekingalpha.com/symbol/TXCLF' title='TXCELL, NICE'>OTC:TXCLF</a>) have <a href=\"https://seekingalpha.com/pr/17222198-sangamo-therapeutics-acquire-txcell\" target=\"_blank\">entered</a>       into a definitive agreement on July 20, pursuant to which Sangamo       will acquire a       majority stake of TxCell, and purchase all of its outstanding ordinary shares, at a price       of &euro;2.58 per share in cash, or ~&euro;72M, on a debt-free       and cash-free basis. Sangamo expects to complete the transaction in Q4.</li>                    <li>The proposed acquisition would combine Sangamo&rsquo;s ex&nbsp;vivo gene&nbsp;editing capabilities and TxCell&rsquo;s Treg expertise and would position Sangamo as a leader in CAR-Treg development.</li><li>Shares of SGMO are up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li><li><strong>Update</strong>: On September 19, TxCell <a href=\"https://seekingalpha.com/pr/17274902-txcell-announces-first-half-2018-financial-results-update-proposed-acquisition-sangamo\" target=\"_blank\">stated </a>Sangamo will own ~53% of its share capital after the transaction.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3372307\" data-linked=\"Sangamo Therapeutics to acquire TxCell\" data-tweet=\"$SGMO $SGMO $TXCLF - Sangamo Therapeutics to acquire TxCell https://seekingalpha.com/news/3372307-sangamo-therapeutics-to-acquire-txcell?source=tweet\" data-url=\"https://seekingalpha.com/news/3372307-sangamo-therapeutics-to-acquire-txcell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372308\" data-ts=\"1532348355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNC\" target=\"_blank\">CNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372308-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Centene (NYSE:<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a>) initiated with Overweight rating and $158 (17% upside) price target at Barclays.</li><li>Molina Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a>) initiated with Equal Weight rating and $105 (flat) price target at Barclays.</li><li>WellCare Health Plans (NYSE:<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a>) initiated with Overweight rating and $288 (12% upside) price target at Barclays.</li><li>Amneal Pharmaceuticals (NYSE:<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a>) initiated with Overweight rating and $22 (19% upside) price target at Morgan Stanley.</li><li>Translate Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/TBIO' title='Translate Bio'>TBIO</a>) initiated with Outperform rating and $24 (50% upside) price target at Leerink Partners.</li><li>Wave Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a>) initiated with Buy rating and $49 (26% upside) price target at H.C. Wainwright.</li><li>Tricida (NASDAQ:<a href='https://seekingalpha.com/symbol/TCDA' title='Tricida, Inc.'>TCDA</a>) initiated with Outperform rating and $50 (69% upside) price target at Cowen and Company. Initiated with Neutral rating and $34 price target at JPMorgan. Initiated with Neutral rating and $32 price target at Goldman Sachs.</li><li>Ironwood Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IRWD' title='Ironwood Pharmaceuticals, Inc.'>IRWD</a>) initiated with Sell rating and $12.50 (38% downside risk) price target at H.C. Wainwright citing valuation, slowing sales of Linzess, lackluster performance of linaclotide ex-U.S., commercial disappointments with gout franchise and recent clinical setbacks in pipeline.</li><li>Kindred Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/KIN' title='Kindred Biosciences, Inc.'>KIN</a>) initiated with Buy rating and $30 (133% upside) price target at Lake Street.</li><li>Aerpio Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ARPO' title='AERPIO PHARMS INC'>OTCQB:ARPO</a>) initiated with Buy rating and $10 (140% upside) price target at Needham.</li><li>REGENXBIO (NASDAQ:<a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a>) downgraded to Neutral at BofA/Merrill Lynch. Shares down&nbsp;<font color='red'>3%&nbsp;</font>premarket.</li><li>Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) downgraded to Market Perform at Cowen. Shares down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3372308\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$CNC $CNC $MOH - Premarket analyst action - healthcare https://seekingalpha.com/news/3372308-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3372308-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372306\" data-ts=\"1532348287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372306-halliburton-slips-after-in-line-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halliburton slips after in-line Q2 results</a></h4><ul>     <li>Halliburton (NYSE:<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a>) <font color='red'>-1.2%</font> premarket as essentially in-line <a href=\"https://seekingalpha.com/news/3372241-halliburton-eps-line-beats-revenue\" target=\"_blank\">Q2 earnings</a> and revenues appear to underwhelm investors.</li>     <li>HAL says its Q2 North America revenue rose 28% Y/Y to $3.83B, driven by the U.S. land sector, while revenue from its international business added 6% Y/Y to  $2.19B, as rising sales in Europe, Africa and combined independent states, and the  Middle East and Asia helped offset a decline in Latin America.</li><li>Q2 completion and production revenue climbed 33% to $4.16B, while drilling and evaluation rose 9% to $1.98B.</li><li>HAL said it is &ldquo;better positioned for the international recovery than it ever has been,\" and calls North America the &ldquo;largest and fastest growing energy market in the world.\"</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3372306\" data-linked=\"Halliburton slips after in-line Q2 results\" data-tweet=\"$HAL - Halliburton slips after in-line Q2 results https://seekingalpha.com/news/3372306-halliburton-slips-after-in-line-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3372306-halliburton-slips-after-in-line-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3372304\" data-ts=\"1532348030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3372304-mattel-higher-after-hasbro-tops-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattel higher after Hasbro tops estimates</a></h4><ul> <li>Shares of Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) are <font color='green'>up 3.32%</font> after peer Hasbro reports Q2 results ahead of expectations.</li> <li>Mattel is due to report on July 25. Analysts expect the toy company to disclose revenue of $852M and EPS of -$0.29.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3372234-hasbro-beats-0_18-beats-revenue\" target=\"_blank\">Hasbro beats by $0.18, beats on revenue</a> (July 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3372242-hasbro-beat-estimates-q2-shares-3_3-percent-premarket\" target=\"_blank\">Hasbro beat estimates in Q2, shares up 3.3% premarket</a> (July 23)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3372304\" data-linked=\"Mattel higher after Hasbro tops estimates\" data-tweet=\"$MAT - Mattel higher after Hasbro tops estimates https://seekingalpha.com/news/3372304-mattel-higher-after-hasbro-tops-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3372304-mattel-higher-after-hasbro-tops-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}